Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
CMP-N-acetylneuraminate + 2 ferrocytochrome b5 + O2 + 2 H+ = CMP-N-glycoloylneuraminate + 2 ferricytochrome b5 + H2O
-
CMP-N-acetylneuraminate + 6,7-dimethyl-5,6,7,8-tetrahydrobiopterin + O2 = CMP-N-glycoloylneuraminate + ?
-
CMP-N-acetylneuraminate + ascorbic acid + O2 = CMP-N-glycoloylneuraminate + dehydroascorbate + H2O
-
CMP-N-acetylneuraminate + ferrocytochrome b5 + O2 + H+ = CMP-N-glycoloylneuraminate + ferricytochrome b5 + H2O
-
CMP-N-acetylneuraminate + ferrocytochrome b5 + O2 = CMP-N-glycoloylneuraminate + ferricytrochrome b5 + H2O
-
CMP-N-acetylneuraminate + NADH + O2 = CMP-N-glycoloylneuraminate + NAD+ + H2O
639314, 639315, 639319, 639321, 639327, 639334, 639313, 639329, 639333, 639320, 639325, 639331, 639332, 639326, 586940, 639328
-
CMP-N-acetylneuraminate + NADPH + O2 = CMP-N-glycoloylneuraminate + NADP+ + H2O
-
S-adenosyl-L-methionine + CMP-N-acetylneuraminic acid = S-adenosyl-L-homocysteine + CMP-N-acetyl-8-O-methyl-neuraminate
-
acetyl-CoA + CMP-Neu5Ac = CoA + ?
-
acetyl-CoA + CMP-N-acetyl-neuraminate = CoA + CMP-9-O-acetyl-N-acetylneuraminate
-
acetyl-CoA + CMP-N-acetylneuraminate = CoA + N-acetyl-9-O-acetylneuraminate + CMP
-
acetyl-CoA + CMP-N-acetylneuraminic acid = CoA + CMP-N-acetyl-7-O-acetyl-neuraminate
-
acetyl-CoA + CMP-N-acetylneuraminic acid = CoA + CMP-N-acetyl-7-O-acetylneuraminic acid
-
acetyl-CoA + CMP-N-acetylneuraminic acid = CoA + CMP-N-acetyl-9-O-acetyl-neuraminate
-
CMP-N-acetylneuraminic acid + acetyl-CoA = CoA + CMP-5-N-acetyl-9-O-acetyl neuraminic acid
-
CMP-N-acetyl-beta-neuraminate + alpha-1-antitrypsin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + asialo-alpha-1-antitrypsin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = CMP + fetuin
-
CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosyl-R
-
CMP-N-acetyl-beta-neuraminate + desialylated fetuin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + human butyrylcholinesterase = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + integrin-beta1 = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + intercellular adhesion molecule-1 = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-N-acetyllactosaminide = CMP + methyl alpha-N-acetylneuraminyl-(2->6)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranoside
-
CMP-N-acetyl-beta-neuraminate + N-acetyl-D-lactosamine = ?
-
CMP-N-acetyl-beta-neuraminate + N-acetyllactosamin-butyl = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + PrPc = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + PrPSc = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + recombinant alpha-1-antitrypsin = CMP + ?
-
CMP-N-acetylneuraminate + (2S,3S,4R,5R,6R)-5-acetylamino-4-hydroxy-6-methoxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-carboxylic acid methyl ester = CMP + ?
-
CMP-N-acetylneuraminate + (2S,3S,4R,5R,6R)-5-acetylamino-4-hydroxy-6-methoxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-carboxylic acid methylamide = CMP + ?
-
CMP-N-acetylneuraminate + (Gal-3-O-Me)beta(1-3)(GlcNAc-6-O-Me)beta-O-Me = CMP + ?
-
CMP-N-acetylneuraminate + (Gal-3-O-Me)beta(1-3)GlcNAcbeta-O-Me = CMP + ?
-
CMP-N-acetylneuraminate + (Galbeta(1,4))2(GlcNAcbeta(1,2))2(Man)3(GlcNAc)2-Asn-Fmoc = ?
-
CMP-N-acetylneuraminate + (GalNAcbeta(1,4))2(GlcNAcbeta(1,2))2(Man)3(GlcNAc)2-Asn-Fmoc = ?
-
CMP-N-acetylneuraminate + 4-methylumbelliferyl beta-D-lactoside = ?
-
CMP-N-acetylneuraminate + 4-nitrophenyl beta-D-galactopyranosyl-(1->3)-N-acetyl-beta-D-glucosaminide = CMP + 4-nitrophenyl N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactopyranosyl-(1->3)-N-acetyl-beta-D-glucosaminide
-
CMP-N-acetylneuraminate + 4-nitrophenyl beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminide = CMP + 4-nitrophenyl N-acetyl-alpha-neuraminyl-(2->6)-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminide
-
CMP-N-acetylneuraminate + 4-nitrophenyl N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminide = CMP + 4-nitrophenyl N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-beta-D-galactosaminyl-(1->4)-N-acetyl-beta-D-glucosaminide
-
CMP-N-acetylneuraminate + 4-nitrophenyl-D-galactoside = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-(4-nitro)phenol
-
CMP-N-acetylneuraminate + 5-(5-dimethylaminonaphthalene-1-sulfonyl-2-(2-aminoethoxy))ethyl beta-lactose = CMP + ?
-
CMP-N-acetylneuraminate + 5-(5-dimethylaminonaphthalene-1-sulfonyl-2-(2-aminoethoxy))ethyl beta-N-acetyllactosamine = CMP + 5-(5-dimethylaminonaphthalene-1-sulfonyl-2-(2-aminoethoxy)) ethyl beta-N-acetylneuraminic acid alpha-2,6-N-acetyllactosamine
-
CMP-N-acetylneuraminate + 6'-sialyl-N-acetyl-D-lactosamine = ?
-
CMP-N-acetylneuraminate + AA-labeled 6'-sialyllactose = ?
-
CMP-N-acetylneuraminate + AA-labeled G2 glycan = ?
-
CMP-N-acetylneuraminate + alpha1-acid glycoprotein = CMP + ?
-
CMP-N-acetylneuraminate + asialo-agalacto-prothrombin = CMP + agalacto-prothrombin
-
CMP-N-acetylneuraminate + asialo-alpha1-acid glycoprotein = CMP + ?
-
CMP-N-acetylneuraminate + asialo-alpha1-acid glycoprotein = CMP + alpha1-acid glycoprotein
-
CMP-N-acetylneuraminate + asialo-apoceruloplasmin = CMP + apoceruloplasmin
-
CMP-N-acetylneuraminate + asialo-ceruloplasmin = CMP + ceruloplasmin
-
CMP-N-acetylneuraminate + asialo-chorionic gonadotropin = CMP + chorionic gonadotropin
-
CMP-N-acetylneuraminate + asialo-fetuin = CMP + fetuin
637272, 637273, 637294, 637296, 637297, 637267, 637271, 637268, 637275, 637276, 659082, 658835
-
CMP-N-acetylneuraminate + asialo-fibrinogen = CMP + fibrinogen
-
CMP-N-acetylneuraminate + asialo-immunoglobulin G = CMP + immunoglobulin G
-
CMP-N-acetylneuraminate + asialo-immunoglobulin M = CMP + immunoglobulin M
-
CMP-N-acetylneuraminate + asialo-orosomucoid = CMP + orosomucoid
636803, 637274, 637273, 637275, 636798, 637272, 637259, 637276, 637291, 637295, 637296, 637267, 637269, 637270, 637288, 637287
-
CMP-N-acetylneuraminate + asialo-proteose peptone = CMP + proteose peptone
-
CMP-N-acetylneuraminate + asialo-prothrombin = CMP + prothrombin
-
CMP-N-acetylneuraminate + asialo-Tamm-Horsfall glycoprotein = CMP + Tamm-Horsfall glycoprotein
-
CMP-N-acetylneuraminate + asialo-thyroglobulin = CMP + thyroglobulin
-
CMP-N-acetylneuraminate + asialo-thyroglobulin glycopeptide = CMP + thyroglobulin glycopeptide
-
CMP-N-acetylneuraminate + asialo-transferrin = CMP + transferrin
-
CMP-N-acetylneuraminate + asialofetuin = ?
-
CMP-N-acetylneuraminate + asialoovomucoid = CMP + ?
-
CMP-N-acetylneuraminate + beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine = CMP + alpha-N-acetylneuraminyl-(2->6)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosamine
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,3-N-acetyl-beta-D-glucosamine = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,3-N-acetyl-beta-D-glucosamine
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,3-N-acetyl-beta-D-glucosaminyl-1,3-galactosyl-beta-1,4-D-glucose = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,3-N-acetyl-beta-D-glucosaminyl-1,3-galactosyl-beta-1,4-D-glucose
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-beta-D-glucosylceramide = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-beta-D-glucosylceramide
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
659397, 659082, 722835, 637288, 722679, 721384, 722367, 637276, 637275, 722570, 637286, 637273, 637292, 637269, 637289, 637290
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine-R = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine-R
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,2-alpha-mannosyl-1,6-beta-mannosyl-1,4-N-acetylglucosamine = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,2-alpha-mannosyl-1,6-beta-mannosyl-1,4-N-acetylglucosamine
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,4-beta-D-galactosyl-1,4-beta-D-glucosyl-beta1-ceramide = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,4-beta-D-galactosyl-1,4-beta-D-glucosyl-beta1-ceramide
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-R = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-R
637273, 637291, 637296, 636803, 637269, 637288, 636796, 637268, 637275, 637290, 637267, 637284, 637257, 636798, 637270, 637272, 637260, 637286, 637259, 637276, 637285, 637292, 637294, 637295, 637297, 637271, 637283, 637293, 637274, 637289, 637287
-
CMP-N-acetylneuraminate + fetuin = ?
-
CMP-N-acetylneuraminate + formic acid (2R,3R,4S,5R,6R)-2-((2R,3R,4R,5R,6R)-3-acetylamino-5-hydroxy-2-methoxy-6-methylaminomethyl-tetrahydro-pyran-4-yloxy)-4,5-dihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl ester = CMP + ?
-
CMP-N-acetylneuraminate + fucosyl-alpha-1,2-D-galactosyl-beta-1,4-D-glucose = ?
-
CMP-N-acetylneuraminate + fucosyllactose = CMP + alpha-N-acetylneuraminyl-2,6-[alpha-L-fucopyranosyl-1,2]-beta-D-galactopyranosyl-1,4-D-glucopyranose
-
CMP-N-acetylneuraminate + Gal-beta-1,3-GlcNAc-beta-OMe = ?
-
CMP-N-acetylneuraminate + galactin-1 = CMP + ?
-
CMP-N-acetylneuraminate + Galbeta(1-3)(GlcNAc-6-O-Me)beta-O-Me = CMP + ?
-
CMP-N-acetylneuraminate + Galbeta(1-3)-GlcNAcbeta(1-3)Galbeta(1-4)Glc = CMP + NeuNAcalpha(2-6)-Galbeta(1-3)GlcNAcbeta(1-3)Galbeta(1-4)Glc
-
CMP-N-acetylneuraminate + Galbeta(1-3)GlcNAcbeta-O-Me = CMP + NeuAcalpha(2-6)Galbeta(1-3)GlcNAcbeta-O-Me
-
CMP-N-acetylneuraminate + Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc = CMP + alpha-N-acetylneuraminyl-(2-6)Galbeta(1-4)GlcNAcbeta(1-3)Galbeta(1-4)Glc
-
CMP-N-acetylneuraminate + Galbeta(1->3)GalNAc = CMP + NeuAcalpha(2->6)Galbeta(1->3)GalNAc
-
CMP-N-acetylneuraminate + Galbeta(1->3)GlcNAc = CMP + NeuAcalpha(2->6)Galbeta(1->3)GlcNAc
-
CMP-N-acetylneuraminate + Galbeta(1->4)GlcNAcbeta(1->2)Manalpha(1->6)[Galbeta(1->4)GlcNAcbeta(1>2)Manalpha(1->3)]Manbeta(1->4)GlcNAcbeta(1->4)GlcNAc-pyridylamine = CMP + NeuAcalpha(2->6)Galbeta(1->4)GlcNAcbeta(1->2)Manalpha(1->6)[Galbeta(1->4)GlcNAcbeta(1>2)Manalpha(1->3)]Manbeta(1->4)GlcNAcbeta(1->4)GlcNAc-pyridylamine
-
CMP-N-acetylneuraminate + Galbeta(1->4)GlcNAcbeta(1->3)Galbeta(1->4)Glcbeta(1<->1)ceramide = CMP + NeuAcalpha(2->6)Galbeta(1->4)GlcNAcbeta(1->3)Galbeta(1->4)Glcbeta(1<->1)ceramide
-
CMP-N-acetylneuraminate + Galbeta-4-nitrophenyl = ?
-
CMP-N-acetylneuraminate + GalNAcbeta-4-nitrophenyl = ?
-
CMP-N-acetylneuraminate + GalNAcbeta1,4-GlcNAc-R = CMP + alpha-N-acetylneuraminyl-2,6-GalNAcbeta1,4-GlcNAc-R
-
CMP-N-acetylneuraminate + glycano-(1->3)-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP + glycano-[(2->6)-alpha-N-acetylneuraminyl]-(N-acetyl-D-galactosaminyl)-glycoprotein
-
CMP-N-acetylneuraminate + lacto-N-neotetraose = ?
-
CMP-N-acetylneuraminate + lacto-N-neotetraose = CMP + ?
-
CMP-N-acetylneuraminate + lacto-N-tetraose = CMP + ?
-
CMP-N-acetylneuraminate + lactosamine = ?
-
CMP-N-acetylneuraminate + lactose = CMP + 6'-sialyllactose
637273, 637270, 686968, 637289, 637290, 738338, 687452, 637268, 637269, 637275, 686979, 722570
-
CMP-N-acetylneuraminate + lactose = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-beta-D-glucose
-
CMP-N-acetylneuraminate + methanesulfonic acid (2R,3S,4R,5R,6R)-5-acetylamino-4-hydroxy-6-methoxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-ylmethyl ester = CMP + ?
-
CMP-N-acetylneuraminate + methyl-alpha-D-galactopyranoside = ?
-
CMP-N-acetylneuraminate + methyl-beta-D-galactopyranoside = ?
-
CMP-N-acetylneuraminate + methyl-beta-D-galactopyranoside = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-methylgalactopyranoside
-
CMP-N-acetylneuraminate + N-((1R,3R,5R,6R,7S,8R,13R,15R,16R,17S)-6,7,17-trihydroxy-5-hydroxymethyl-15-methoxy-2,4,9,11,14-pentaoxa-tricyclo[11.3.1.03,8]heptadec-16-yl)-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18R)-6,7,18-trihydroxy-5-hydroxymethyl-16-methoxy-11-oxo-2,4,9,15-tetraoxa-12-aza-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-((1R,3R,5R,6R,7S,8R,14R,16R,17R,18S)-6,7,18-trihydroxy-5-hydroxymethyl-16-methoxy-2,4,9,12,15-pentaoxa-tricyclo[12.3.1.03,8]octadec-17-yl)-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-acetyl-D-galactosamine = ?
-
CMP-N-acetylneuraminate + N-acetyllactosamine = ?
-
CMP-N-acetylneuraminate + N-[(2R,3R,4R,5S,6R)-4-hydroxy-6-(methanesulfonylamino-methyl)-2-methoxy-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-[(2R,3R,4R,5S,6R)-5-((2S,3R,4S,5R,6R)-4,5-dihydroxy-6-hydroxymethyl-3-methoxy-tetrahydro-pyran-2-yloxy)-6-formylaminomethyl-4-hydroxy-2-methoxy-tetrahydro-pyran-3-yl]-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-[(2R,3R,4R,5S,6R)-6-(acetylamino-methyl)-4-hydroxy-2-methoxy-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + N-[(2R,3R,4R,5S,6R)-6-aminomethyl-4-hydroxy-2-methoxy-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-3-yl]-acetamide = CMP + ?
-
CMP-N-acetylneuraminate + Neu5Acalpha-2,3-Galbeta-1,4-Glc = CMP + alpha-N-acetylneuraminyl-2,6-(Neu5Acalpha-2,3-)Galbeta-1,4-Glc
-
CMP-N-acetylneuraminate + ovomucoid = CMP + ?
-
CMP-N-acetylneuraminate + pyridylamine-type 2H = CMP + alpha2,6-sialylated blood group type 2H antigen
-
CMP-N-acetylneuraminate + pyridylamino-lactose = CMP + alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-beta-D-glucosyl-pyridylaminoside
-
CMP-N-acetylneuraminate + pyridylamino-N-acetyllactosamine = ?
-
CMP-N-acetylneuraminate + pyridylaminyl-lacto-N-neotetraose = CMP + ?
-
CMP-N-acetylneuraminate + submaxillary asialo-mucin = CMP + submaxillary mucin
-
CMP-N-acetylneuraminate + tumor necrosis factor receptor 1 = CMP + alpha2,6-sialyated tumor necrosis factor receptor 1
-
asialo-alpha1-acidglycoprotein + CMP-Neu5Ac = ?
-
CMP-Neu5Ac + lactose = CMP + Neu5Acalpha(2-6)Lac
-
CMP-Neu5Ac + methyl-beta-D-galactopyranoside = CMP + Neu5Acalpha(2-6)Gal-alpha-methyl
-
CMP-Neu5Ac + N-acetyllactosamine = CMP + Neu5Acalpha(2-6)LacNAc
-
Galbeta(1,4)GlcNAc-octyl + CMP-Neu5Ac = ?
-
GalNAcbeta(1,4)GlcNAc-octyl + CMP-Neu5Ac = ?
-
CMP-N-acetyl-beta-neuraminate + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + N-acetylneuramin-lacto-N-tetraose a = CMP + disialyllacto-N-tetraose
-
2 CMP-N-acetyl-beta-neuraminate + 2 methyl beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal = 2 CMP + methyl alpha-Neu5Ac-(2->2)-beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal + methyl alpha-Neu5Ac-(2->4)-beta-D-(3-O-sulfo)Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal
-
CMP-N-acetyl-beta-neuraminate + 2-azidoethyl beta-D-Gal-(1->3)-beta-D-GalNAc = CMP + 2-azidoethyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + 3-O-[beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester = CMP + 3-O-[alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc]-N-acetyl-L-threonine methyl ester
-
CMP-N-acetyl-beta-neuraminate + a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R = CMP + an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + agalactofetuin = ?
-
CMP-N-acetyl-beta-neuraminate + allyl beta-D-Gal-(1->3)-beta-D-GalNAc = CMP + allyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + allyl beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + allyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + antifreeze protein = ?
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = ?
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + asialotransferrin = ?
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->3)-beta-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-(2-O-Me)Gal-(1->3)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-(2-O-Me)Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->3)-beta-D-GalNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-beta-D-galactosyl-(1->3)-beta-D-glucosyl-(1->4)-R = ?
-
CMP-N-acetyl-beta-neuraminate + beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + beta-Gal-(1->4)-beta-GlcNAc-R = CMP + alphaNeuAc-(2->3)-beta-Gal-(1->4)-beta-GlcNAc-R
-
CMP-N-acetyl-beta-neuraminate + Galbeta(1->3)(GlcNAcbeta(1->6))GalNAc-OBn = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + Galbeta(1->3)GalNAc-OBn = CMP + Neu5Acalpha(2->3)Galbeta(1->3)GalNAc-OBn
-
CMP-N-acetyl-beta-neuraminate + ganglioside GA1 = CMP + ganglioside GM1b
-
CMP-N-acetyl-beta-neuraminate + ganglioside Gb5 = CMP + ganglioside MSGb5
-
CMP-N-acetyl-beta-neuraminate + ganglioside GD1a = ?
-
CMP-N-acetyl-beta-neuraminate + ganglioside GD1a = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + ganglioside GD1b = CMP + ganglioside GT1b
-
CMP-N-acetyl-beta-neuraminate + ganglioside GL-2a = CMP + ganglioside GM3
-
CMP-N-acetyl-beta-neuraminate + ganglioside GM1 = ?
-
CMP-N-acetyl-beta-neuraminate + ganglioside GM1 = CMP + ganglioside GD1
-
CMP-N-acetyl-beta-neuraminate + ganglioside GM1a = CMP + ganglioside GD1a
745103, 744832, 745046, 745082, 744207, 744836, 745272, 637745, 637747, 636888, 637736, 637737, 637738, 637741, 637742, 637746, 739511, 745233, 764079
-
CMP-N-acetyl-beta-neuraminate + ganglioside GM2 = ?
-
CMP-N-acetyl-beta-neuraminate + ganglioside GM3 = CMP + ganglioside GD3
-
CMP-N-acetyl-beta-neuraminate + gangloside asialo-GM1 = CMP + ganglioside GM1b
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal
-
CMP-N-acetyl-beta-neuraminate + porcine submaxillary asialo-mucin = ?
-
CMP-N-acetyl-beta-neuraminate + [asialofetuin]-(O-3-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->)))-L-serine = CMP + [protein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->)))-L-serine
-
CMP-N-acetyl-beta-neuraminate + [asialofetuin]-(O-3-(beta-D-Gal-(1->3)-beta-D-GalNAc-(1->)))-L-threonine = CMP + [protein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->)))-L-threonine
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->3)-beta-D-GalNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-R
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = CMP + fetuin
-
CMP-N-acetyl-beta-neuraminate + N-acetyllactosamin-butyl = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + recombinant alpha-1-antitrypsin = CMP + ?
-
CMP-N-acetylneuraminate + antifreeze glycoprotein = ?
-
CMP-N-acetylneuraminate + asialo-fetuin = CMP + fetuin
-
CMP-N-acetylneuraminate + asialo-milk glycopeptide = CMP + milk glycopeptide
-
CMP-N-acetylneuraminate + asialo-orosomucoid = CMP + orosomucoid
-
CMP-N-acetylneuraminate + asialo-polysialoglycoprotein = CMP + alpha-sialosyl-(2-6)-asialo-polysialoglycoprotein
-
CMP-N-acetylneuraminate + erythrocyte hemagglutination inhibitor = ?
-
CMP-N-acetylneuraminate + Galbeta(1-3)GalNAc-R = CMP + Galbeta(1-3)(NeuAcalpha(2-6))GalNAc-R
-
CMP-N-acetylneuraminate + GalNAc-R = CMP + NeuAcalpha(2-6)GalNAc-R
-
CMP-N-acetylneuraminate + glycano-(1->3)-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP + glycano-[(2->6)-alpha-N-acetylneuraminyl]-(N-acetyl-D-galactosaminyl)-glycoprotein
-
CMP-N-acetylneuraminate + glycano-1,3-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP + glycano-(2,6-alpha-N-acetylneuraminyl)-(N-acetyl-D-galactosaminyl)-glycoprotein
636807, 636805, 636797, 636806, 636808, 636802, 636796, 636798, 636795, 636794, 636800, 636804, 636809
-
CMP-N-acetylneuraminate + GTTPSPVPT[GalNAc]TSTTSAP = CMP + GTTPSPVPT[Neu5Acalpha(2-6)GalNAc]TSTTSAP
-
CMP-N-acetylneuraminate + lactose = CMP + 6'-sialyllactose
-
CMP-N-acetylneuraminate + native fetuin = ?
-
CMP-N-acetylneuraminate + native polysialoglycoprotein = ?
-
CMP-N-acetylneuraminate + NeuAcalpha(2-3)Galbeta(1-3)GalNAc-R = CMP + NeuAcalpha(2-3)Galbeta(1-3)(NeuAcalpha(2-6))GalNAc-R
-
CMP-N-acetylneuraminate + p-nitrophenyl-beta-D-galactoside = CMP + alpha-sialosyl-(2-6)-p-nitrophenyl-beta-D-galactoside
-
CMP-N-acetylneuraminate + protein MUC1-MFP6 = ?
-
CMP-N-acetylneuraminate + R-1,3-(N-acetyl-alpha-D-galactosaminyl)-glycoprotein = CMP + R-(2,6-alpha-N-acetylneuraminyl)-(N-acetyl-D-galactosaminyl)-glycoprotein
636809, 636800, 636794, 636797, 636796, 636805, 636807, 636795, 636798, 636802, 636808, 636799, 636804, 636801, 636806, 636803
-
CMP-N-acetylneuraminate + submaxillary asialo-mucin = CMP + submaxillary mucin
-
CMP-N-acetylneuraminate + VPSTPPTPSPSTPPTPSPSCCHPR-GalNAc = CMP + ?
-
CMP-Neu5Ac + asialofetuin = CMP + ?
-
CMP-Neu5Ac + fetuin = CMP + ?
-
CMP-Neu5Ac + HIV 120gp (17-mer) = CMP + ?
-
CMP-Neu5Ac + HIV 120gp (21-mer) = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + 2-nitrophenyl D-galactose = ?
-
CMP-N-acetyl-beta-neuraminate + a beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R = CMP + an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + a beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R = CMP + an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + a type 3 histo-blood group antigen precursor disaccharide = an N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R + CMP + H+
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = ?
-
CMP-N-acetyl-beta-neuraminate + asialofetuin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + benzyl 2-acetamido-2-deoxy-3-O-(beta-D-galactopyranosyl)-alpha-D-galactopyranoside = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->3)-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + Galbeta(1->3)(GlcNAcbeta(1->6))GalNAc-OBn = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + Galbeta(1->3)GalNAc-OBn = CMP + Neu5Acalpha(2->3)Galbeta(1->3)GalNAc-OBn
-
CMP-N-acetyl-beta-neuraminate + lactose = CMP + 3'-sialyllactose + N-acetyl-beta-D-neuraminate
-
CMP-N-acetyl-beta-neuraminate + lactose = CMP + alpha2,3-SiaLac + Neu5Ac
-
CMP-N-acetyl-beta-neuraminate + octyl beta-D-Gal-(1->3)-alpha-D-GalNAc = CMP + octyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + [antifreeze glycoprotein]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine = CMP + [antifreeze glycoprotein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine
-
CMP-N-acetyl-beta-neuraminate + [antifreeze glycoprotein]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine = CMP + [antifreeze glycoprotein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine
-
CMP-N-acetyl-beta-neuraminate + [asialoglycoprotein]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine = CMP + [asialoglycoprotein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine
-
CMP-N-acetyl-beta-neuraminate + [asialoglycoprotein]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine = CMP + [asialoglycoprotein]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine
-
CMP-N-acetyl-beta-neuraminate + [porcine submaxillary asialo-mucin]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine = CMP + [porcine submaxillary asialo-mucin]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-serine
-
CMP-N-acetyl-beta-neuraminate + [porcine submaxillary asialo-mucin]-(O-3-(beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine = CMP + [porcine submaxillary asialo-mucin]-(O-3-(alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->)))-L-threonine
-
CMP-N-acetylneuraminate + 4-methylumbelliferyl 4-O-beta-D-galactosyl-beta-D-glucoside = CMP + 4-methylumbelliferyl alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucoside
-
CMP-N-acetylneuraminate + 4-nitrophenyl beta-D-Gal-(1->3)-alpha-D-GalNAc = CMP + 4-nitrophenyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-alpha-D-GalNAc
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->3)-beta-D-GalNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc
-
CMP-N-acetylneuraminate + beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R = CMP + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-R
-
CMP-N-acetylneuraminate + lactose = CMP + NeuAcalpha(2->3)Galbeta(1->4)Glc
-
CMP-N-acetyl-beta-neuraminate + asialo-alpha1-acid glycoprotein = ?
-
CMP-N-acetyl-beta-neuraminate + asialoprothrombin = ?
-
CMP-N-acetyl-beta-neuraminate + asialotransferrin = ?
-
CMP-N-acetyl-beta-neuraminate + Galbeta(1->4)GlcNAc-R = CMP + NeuAcalpa(2->6)Galbeta(1->4)GlcNAc-R
-
CMP-N-acetyl-beta-neuraminate + Galbeta1-3GlcNAcbeta1-1Galbeta1-4Glc = ?
-
CMP-N-acetyl-beta-neuraminate + lacto-N-tetraose = CMP + 6'-(alpha2->6)-siallyllactose + ?
-
CMP-N-acetyl-beta-neuraminate + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-glucosaminyl-R = CMP + N-acetyl-alpha-neuraminyl-(2->3)-beta-D-galactosyl-(1->3)-[N-acetyl-alpha-neuraminyl-(2->6)]-N-acetyl-beta-D-glucosaminyl-R
-
CMP-N-acetyl-beta-neuraminate + prothrombin = ?
-
CMP-N-acetyl-beta-neuraminate + transferrin = ?
-
CMP-N-acetylneuraminate + 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol = CMP + 1,2-diacyl-3-[3-(alpha-D-N-acetylneuraminyl)-beta-D-galactosyl]-sn-glycerol
-
CMP-N-acetylneuraminate + Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc = CMP + ?
-
CMP-N-acetylneuraminate + Galbeta1-3GlcNAcR = CMP + NeuAcalpha2-3Galbeta1-3GlcNAcR
-
CMP-N-acetylneuraminate + Galbeta1-4GlcNAc = CMP + NeuAcalpha2-3Galbeta1-4GlcNAc
-
CMP-N-acetylneuraminate + Galbeta1-4GlcNAcR = CMP + NeuAcalpha2-3Galbeta1-4GlcNAcR
-
CMP-N-acetylneuraminic acid + 1,2-diacyl-3-beta-D-galactosyl-sn-glycerol = CMP + 1,2-diacyl-3-[3-(alpha-D-N-acetyl-neuraminyl)-beta-D-galactosyl]-sn-glycerol
-
CMP-N-acetylneuraminic acid + NeuAcalpha-(2-3)-Galbeta-(1-4)-GlcNAcbeta-1-octyl = ?
-
CMP-N-acetyl-beta-neuraminate + 4-methylumbelliferyl beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + 4-methylumbelliferyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + 4-methylumbelliferyl beta-lactoside = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc
-
CMP-N-acetyl-beta-neuraminate + 4-methylumbelliferyl beta-Lewis x = CMP + 4-methylumbelliferyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + 4-nitrophenyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal = CMP + 4-nitrophenyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal
-
CMP-N-acetyl-beta-neuraminate + 4-nitrophenyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + 4-nitrophenyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + 8-methoxy-8-oxooctyl beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + 8-methoxy-8-oxooctyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + allyl beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + allyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-(3-F)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-(3-F)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-(3-O-Me)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-(3-O-Me)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-(4-O-Me)Gal-(1->4)-beta-D-GlcNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-(4-O-Me)Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-(4-O-Me)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-(4-O-Me)Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[4-deoxy-4-fluoro-beta-D-Gal-(1->3)]-beta-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[4-deoxy-4-fluoro-beta-D-Gal-(1->3)]-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(3-F)Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(3-F)Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(3-O-Me)Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(3-O-Me)Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(4-O-Me)Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-(4-O-Me)Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-GalNAc
-
CMP-N-acetyl-beta-neuraminate + benzyl beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + benzyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[alpha-NeuAc-(2->3)-beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-(2-O-Me)Gal-(1->4)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-(2-O-Me)Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + alphaNeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->3)-beta-GlcNAc = CMP + alphaNeuAc-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-alpha-D-Glc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-alpha-D-Glc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-Glc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-ceramide = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-ceramide
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + alpha-NeuAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + alphaNeuAc-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + alphaNeuAc-(2->3)-beta-Gal-(1->4)-beta-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)-beta-D-Man-(1->4)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->2)-alpha-D-Man-(1->6)-beta-D-Man-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-ceramide = CMP + ganglioside LM1
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc-R
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-[protein] = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-[protein]
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-N-GlcNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-N-GlcNAc-R
-
CMP-N-acetyl-beta-neuraminate + beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-[protein] = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-[protein]
-
CMP-N-acetyl-beta-neuraminate + beta-D-mannopyranoside = CMP + alpha-Neu5Ac-(2->3)-beta-D-Man
-
CMP-N-acetyl-beta-neuraminate + beta-D-N-acetylgalactosamine = CMP + alpha-Neu5Ac-(2->3)-beta-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + beta-D-N-acetylglucosamine = CMP + alpha-Neu5Ac-(2->3)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + beta1-integrin = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + epidermal growth factor receptor = CMP + ?
-
CMP-N-acetyl-beta-neuraminate + FCHASE beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + FCHASE alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + Lewis X = CMP + sialyl Lewis X
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->4)-beta-D-(6-O-sulfo)GlcNAc-(1->6)-[alphaNeu5Ac-(2->3)-beta-D-Gal-(1->3)]-alpha-GalNAc = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-(6-O-sulfo)GlcNAc-(1->6)-[alphaNeu5Ac-(2->3)-beta-D-Gal-(1->3)]-alpha-GalNAc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->4)-beta-D-(6-O-sulfo)GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-(6-O-sulfo)GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-[alpha-D-Fuc-(1->3)]-beta-D-GlcNAc-(1->6)-[beta-D-Gal-(1->3)]-alpha-D-GalNAc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-galactopyranoside = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Gal
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-galactopyranoside = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-galactopyranoside
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-glucopyranoside = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Glc
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-glucopyranoside = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-glucopyranoside
-
CMP-N-acetyl-beta-neuraminate + methyl beta-D-mannopyranoside = CMP + methyl alpha-Neu5Ac-(2->3)-beta-D-Man
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->3)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GlcNAc
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GalNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GalNAc-R
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-Glc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-Glc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-Glc-R
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-R = CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R
-
CMP-N-acetyl-beta-neuraminate + Neu5Acalpha2-3Galbeta1-3GalNacalpha-O-benzyl = ?
-
CMP-N-acetylneuraminate + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R = CMP + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-(N-acetylneuraminyl-2,6)-N-acetyl-D-galactosaminyl-R
-
CMP-N-acetylneuraminate + alpha1-acid glycoprotein = ?
-
CMP-N-acetylneuraminate + fetuin = ?
-
CMP-N-acetylneuraminate + GlcNac-alpha1-O-benzyl = ?
-
CMP-N-acetylneuraminate + GM1b = CMP + ?
-
CMP-N-acetylneuraminate + monosialylgalactosylgloboside = CMP + disialylgalactosylgloboside
-
CMP-N-acetylneuraminate + N-alpha-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R = CMP + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,3-(N-acetylneuraminyl-2,6)-N-acetyl-D-galactosaminyl-R
-
CMP-N-acetylneuraminate + Neu5Acalpha2-3Galbeta1-3GalNac = ?
-
CMP-N-acetylneuraminate + Neu5Acalpha2-3Galbeta1-4GlcNac-alpha1-O-benzyl = ?
-
CMP-N-acetylneuraminate + NeuAc-alpha-(2->3)-Gal-beta-(1->3)-GalNAc = ?
-
CMP-N-acetylneuraminate + sialyl lactoetraosylceramide = CMP + ?
-
CMP-Neu5Ac + fetuin = ?
-
CMP-Neu5Ac + Galbeta1,3GlcNAcbeta1,3Galbeta1,4Glcbeta1-Cer = ?
-
CMP-Neu5Ac + Galbeta1,4GlcNAcbeta1,3Galbeta1,4Glcbeta1-Cer = ?
-
CMP-NeuAc + glycoprotein = ?
-
CMP-NeuAc + glycosphingolipid = ?
-
CMP-N-acetylneuraminate + (11-azidoundecyl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosid)onic acid = CMP + 11-azidoundecyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid + 11-azidoundecyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid + 11-azidoundecyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid + 11-azidoundecyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid + 11-azidoundecyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid
-
CMP-N-acetylneuraminate + (methyl S-5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-non-2-ulopyranosyl)onic acid = CMP + methyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid + methyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galactonon-2-ulopyranosylonic acid
-
CMP-N-acetylneuraminate + 4-chlorophenyl 6-S-(5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->6)-1,6-dithio-beta-D-galactopyranoside = CMP + 4-chlorophenyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->6)-S-1,6-dithio-beta-D-galactopyranoside
-
CMP-N-acetylneuraminate + a ganglioside GD1a = a ganglioside GT1a + CMP + H+
-
CMP-N-acetylneuraminate + a ganglioside GD3 = a ganglioside GT3 + CMP + H+
-
CMP-N-acetylneuraminate + a ganglioside GM3 = a ganglioside GD3 + CMP + H+
-
CMP-N-acetylneuraminate + a ganglioside GT1b = a ganglioside GQ1b + CMP + H+
-
CMP-N-acetylneuraminate + adenosine A2A receptor = CMP + ?
-
CMP-N-acetylneuraminate + alpha-2,8-linked polysialic acid = ?
-
CMP-N-acetylneuraminate + alpha-2,8-linked polysialic acid = CMP + ?
-
CMP-N-acetylneuraminate + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-R = CMP + alpha-N-acetylneuraminyl-(2->8)-alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-R
-
CMP-N-acetylneuraminate + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-D-glucosylceramide = CMP + alpha-N-acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosaminyl-1,3-beta-D-galactosyl-1,4-D-glucosylceramide
-
CMP-N-acetylneuraminate + beta-sialic acid = CMP + alpha-N-acetylneuraminyl-(2->8)-beta-N-acetylneuraminate
-
CMP-N-acetylneuraminate + bovine submaxillary mucin = CMP + ?
-
CMP-N-acetylneuraminate + disialoganglioside GD1a = CMP + trisialoganglioside GT1a
-
CMP-N-acetylneuraminate + dopamine D1 receptor = CMP + ?
-
CMP-N-acetylneuraminate + dopamine D2 receptor = CMP + ?
-
CMP-N-acetylneuraminate + ganglioside GD3 = ganglioside GT3 + CMP + H+
-
CMP-N-acetylneuraminate + ganglioside GM3 = CMP + ?
-
CMP-N-acetylneuraminate + ganglioside GM3 = CMP + ganglioside GD3
-
CMP-N-acetylneuraminate + ganglioside GM3 = ganglioside GD3 + CMP + H+
-
CMP-N-acetylneuraminate + ganglioside GM3 amide = CMP + ganglioside GD3 amide
-
CMP-N-acetylneuraminate + ganglioside GM3 methyl ester = CMP + ganglioside GD3 methyl ester
-
CMP-N-acetylneuraminate + ganglioside GM3 methylamide = CMP + ganglioside GD3 methylamide
-
CMP-N-acetylneuraminate + ganglioside LM1 = CMP + ganglioside LD1c
-
CMP-N-acetylneuraminate + ganglioside lyso-GM3 = CMP + ganglioside lyso-GD3
-
CMP-N-acetylneuraminate + ganglioside N-acetyl-lyso-GM3 = CMP + ganglioside N-acetyl-lyso-GD3
-
CMP-N-acetylneuraminate + ganglioside N-octanoyl-lyso-GM3 = CMP + ganglioside N-octanoyl-lyso-GD3
-
CMP-N-acetylneuraminate + ganglioside N1-pyrenyl-dodecanoyl-lyso-GM3 = CMP + ganglioside N1-pyrenyl-dodecanoyl-lyso-GD3
-
CMP-N-acetylneuraminate + methyl S-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galactonon-2-ulopyranosylonic acid)-(2->6)-(6-thio-beta-D-galactopyranosyl)-(1->4)-O-beta-D-glucopyranoside = CMP + methyl O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galactonon-2-ulopyranosylonic acid)-(2->8)-(5-acetamido-3,5-dideoxy-2-thio-D-glycero-alpha-D-galacto-non-2-ulopyranosylonic acid)-(2->6)-(6-thio-beta-D-galactopyranosyl)-(1->4)-beta-D-glucopyranoside
-
CMP-N-acetylneuraminate + N-alpha-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide = CMP + alpha-N-acetylneuraminyl-2,8-alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide
637737, 636879, 639653, 637739, 587167, 637736, 637742, 638784, 638788, 639650, 587166
-
CMP-N-acetylneuraminate + N-butyrylneuraminyl-alpha-2,3-galactosyl-beta-1,4-glucosyl-beta-1,1-ceramide = CMP + ?
-
CMP-N-acetylneuraminate + N-glycolylneuraminyl-alpha-2,3-galactosyl-beta-1,4-glucosyl-beta-1,1-ceramide = CMP + ?
-
CMP-N-acetylneuraminate + N-lyso-GM3 = CMP + N-lyso-GD3
-
CMP-N-acetylneuraminate + neural cell adhesion molecule = ?
-
CMP-N-acetylneuraminate + neural cell adhesion molecule = CMP + ?
-
CMP-N-acetylneuraminate + neuropilin-1 = CMP + ?
-
CMP-N-acetylneuraminate + neuropilin-2 = CMP + ?
-
CMP-N-acetylneuraminate + trisialoganglioside GT1b = CMP + ganglioside GQ1b
-
CMP-N-acetylneuraminate + type V adenylyl cyclase = CMP + ?
-
CMP-Neu5Ac + GT3-FCHASE = CMP + long polySia chains + ?
-
beta-D-Gal-(1->4)-beta-D-Glc-(1->1)-Cer(d18:1(4E)) + CMP-N-acetyl-beta-neuraminate = CMP + ganglioside GM3 (d18:1(4E)) + H+
-
CMP-N-acetylneuraminate + 1-deoxy-1-cholesteryl (N-acetyl)-ethanolaminolactitol = CMP + ?
-
CMP-N-acetylneuraminate + 1-deoxy-1-cholesterylethanolaminolactitol = CMP + ?
-
CMP-N-acetylneuraminate + 1-deoxy-1-cholesterylphospho (N-acetyl)-ethanolaminolactitol = CMP + ?
-
CMP-N-acetylneuraminate + 1-deoxy-1-cholesterylphosphoethanolaminolactitol = CMP + ?
-
CMP-N-acetylneuraminate + 2,3-dicholesteryl-1-beta-lactosylglycerol = ?
-
CMP-N-acetylneuraminate + 2-cholesteryl-1-beta-lactosylglycerol = ?
-
CMP-N-acetylneuraminate + 3-cholesteryl-1-beta-lactosylglycerol = ?
-
CMP-N-acetylneuraminate + asialoGM1 = ?
-
CMP-N-acetylneuraminate + asialoGM1 = CMP + GM1
-
CMP-N-acetylneuraminate + asialoGM2 = CMP + GM2
-
CMP-N-acetylneuraminate + beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide = CMP + alpha-N-acetylneuraminyl-(2->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,3-N-acetylgalactosamin-1,4-beta-D-galactosyl-1,4-beta-D-glucosylceramide = CMP + ?
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,3-N-acetylgalactosamin-lactosylceramide = CMP + ?
-
CMP-N-acetylneuraminate + beta-D-galactosyl-1,4-beta-D-glucosylceramide = CMP + N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide
723516, 636879, 638776, 489583, 638793, 636877, 637739, 636888, 637736, 637737, 637742, 638779, 638781, 638782, 638788, 638792, 638785, 638783, 638780, 638791
-
CMP-N-acetylneuraminate + beta-lactosylcholesterol = ?
-
CMP-N-acetylneuraminate + boron dipyrromethene difluoride-lactosylceramide = CMP + boron dipyrromethene difluoride-ganglioside GM3
-
CMP-N-acetylneuraminate + cholesteryl-beta-lactosylpropane-1,3-diol = ?
-
CMP-N-acetylneuraminate + galactosylceramide = ?
-
CMP-N-acetylneuraminate + galactosylceramide = CMP + ?
-
CMP-N-acetylneuraminate + galactosylceramide = CMP + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-ceramide
-
CMP-N-acetylneuraminate + galactosylceramide = CMP + ganglioside GM3
-
CMP-N-acetylneuraminate + glucosylceramide = CMP + ?
-
CMP-N-acetylneuraminate + GM3 = ?
-
CMP-N-acetylneuraminate + lactosylceramide = ?
-
CMP-N-acetylneuraminate + lactosylceramide = CMP + alpha-N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosyl-ceramide
-
CMP-N-acetylneuraminate + lactosylceramide = CMP + ganglioside GM4
-
CMP-N-acetylneuraminate + lactosylceramide = CMP + N-acetylneuraminyl-2,3-beta-D-galactosyl-1,4-beta-D-glucosylceramide
-
CMP-Neu5Ac + lactosylceramide = ?
-
CMP-sialic acid + galactosylceramide = CMP + ganglioside GM4
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Uridine diphosphate N-acetyl-D-glucosamine 2-epimerase from rat liver. I. Catalytic and regulatory properties
1972
Sommar, K.M.; Ellis, D.B.
Biochim. Biophys. Acta
268
581-589
Purification and properties of UDP-N-acetylglucosamine 2'-epimerase from rat liver
1973
Kikuchi, K.; Tsuiki, S.
Biochim. Biophys. Acta
327
193-206
UDP-N-acetylglucosamine 2'-epimerase of rat hepatoma and its comparison with the enzyme of rat liver
1980
Kikuchi, K.; Tsuiki, S.
Tohoku J. Exp. Med.
131
209-214
A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Purification and characterization of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase
1997
Hinderlich, S.; Stäsche, R.; Zeitler, R.; Reutter, W.
J. Biol. Chem.
272
24313-24318
Characterization of the sialate-7(9)-O-acetyltransferase from the microsomes of human colonic mucosa
2002
Shen, Y.; Tiralongo, J.; Iwersen, M.; Sipos, B.; Kalthoff, H.; Schauer, R.
Biol. Chem.
383
307-317
Regulation of ganglioside biosynthesis by enzyme complex formation of glycosyltransferases
2002
Bieberich, E.; MacKinnon, S.; Silva, J.; Li, D.D.; Tencomnao, T.; Irwin, L.; Kapitonov, D.; Yu, R.K.
Biochemistry
41
11479-11487
Biosynthesis in vitro of sialosylgalactosyldiacylglycerol by mouse brain microsomes
1981
Pieringer, J.; Keech, S.; Pieringer, R.A.
J. Biol. Chem.
256
12306-12309
Large-scale expression of recombinant sialyltransferases and comparison of their kinetic properties with native enzymes
1995
Williams, M.A.; Kitagawa, H.; Datta, A.K.; Paulson, J.C.; Jamieson, J.C.
Glycoconjugate J.
12
755-761
A study on the regulation of N-glycoloylneuraminic acid biosynthesis and utilization in rat and mouse liver
1990
Lepers, A.; Shaw, L.; Schneckenburger, P.; Cacan, R.; Verbert, A.; Schauer, R.
Eur. J. Biochem.
193
715-723
Substrate specificity of GM2 and GD3 synthase of Golgi vesicles derived from rat liver
1987
Klein, D.; Pohlentz, G.; Schwarzmann, G.; Sandhoff, K.
Eur. J. Biochem.
167
417-424
Oligosialogangliosides inhibit GM2- and GD3-synthesis in isolated Golgi vesicles from rat liver
1987
Yusuf, H.K.M.; Schwarzmann, G.; Pohlentz, G.; Sandhoff, K.
Biol. Chem. Hoppe-Seyler
368
455-462
Purification to homogeneity and enzymatic characterization of an alpha-N-acetylgalactosaminide alpha 2 leads to 6 sialyltransferase from porcine submaxillary glands
1979
Sadler, J.E.; Rearick, J.I.; Hill, R.L.
J. Biol. Chem.
254
5934-5941
Specificity of submaxillary gland sialyltransferases
1983
Sherblom, A.P.; Bourassa, C.R.
Biochim. Biophys. Acta
761
94-102
Biosynthesis of mammalian glycoproteins. Glycosylation pathways in the synthesis of the nonreducing terminal sequences
1979
Beyer, T.A.; Rearick, J.I.; Paulson, J.C.; Prieels, J.P.; Sadler, J.E.; Hill, R.L.
J. Biol. Chem.
254
12531-12541
Aglycon specificity of fetal calf liver and ovine and porcine submaxillary gland alpha-N-acetylgalactosaminide alpha 2 leads to 6 sialyltransferase
1983
Bergh, M.L.E.; van den Eijnden, D.H.
Eur. J. Biochem.
136
113-118
Sialylation of glycoprotein oligosaccharides with N-acetyl-, N-glycolyl-, and N-O-diacetylneuraminic acids
1985
Higa, H.H.; Paulson, J.C.
J. Biol. Chem.
260
8838-8849
Discrimination between activity of (alpha 2-3)-sialyltransferase and (alpha 2-6)-sialyltransferase in human platelets using p-nitrophenyl-beta-D-galactoside as acceptor
1982
Bauvois, B.; Cacan, R.; Fournet, B.; Caen, J.; Montreuil, J.; Verbert, A.
Eur. J. Biochem.
121
567-572
Purification to homogeneity of a beta-galactoside alpha2 leads to 3 sialyltransferase and partial purification of an alpha-N-acetylgalactosaminide alpha2 leads to 6 sialyltransferase from porcine submaxillary glands
1979
Sadler, J.E.; Rearick, J.I.; Paulson, J.C.; Hill, R.L.
J. Biol. Chem.
254
4434-4443
Sialylation processes in mitochondria: evidence for two distinct sialyltransferases located in the outer membrane
1991
Gasnier, F.; Baubichon-Cortay, H.; Louisot, P.; Gateau-Roesch, O.
J. Biochem.
110
702-707
Specificity of ovine submaxillary-gland sialyltransferases. Application of high-pressure liquid chromatography in the identification of sialo-oligosaccharide products
1982
Bergh, M.L.E.; Koppen, P.L.; Van den Eijnden, D.H.
Biochem. J.
201
411-415
Transfer of synthetic sialic acid analogues to N- and O-linked glycoprotein glycans using four different mammalian sialyltransferases
1989
Gross, H.J.; Rose, U.; Krause, J.M.; Paulson, J.C.; Schmid, K.; Feeney, R.E.; Brossmer, R.
Biochemistry
28
7386-7392
The sialic acids. XVI. Isolation of a mucin sialyltransferase from sheep submaxillary gland
1973
Carlson, D.M.; McGuire, E.J.; Jourdian, G.W.; Roseman, S.
J. Biol. Chem.
248
5763-5773
Developmental expression of trout egg polysialoglycoproteins and the prerequisite alpha2,6-, and alpha2,8-sialyl and alpha2,8-polysialyltransferase activities required for their synthesis during oogenesis
1994
Kitazume, S.; Kitajima, K.; Inoue, S.; Inoue, Y.; Troy, F.A.2nd.
J. Biol. Chem.
269
10330-10340
Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-sialyltransferase is related to poor patient survival in human colorectal carcinomas
2001
Schneider, F.; Kemmner, W.; Haensch, W.; Franke, G.; Gretschel, S.; Karsten, U.; Schlag, P.M.
Cancer Res.
61
4605-4611
Identification and functional characterization of a human GalNAc alpha2,6-sialyltransferase with altered expression in breast cancer
2002
Sotiropoulou, G.; Kono, M.; Anisowicz, A.; Stenman, G.; Tsuji, S.; Sager, R.
Mol. Med.
8
42-55
-
Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac:GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA
2001
Julien, S.; Krzewinski-Recchi, M.A.; Harduin-Lepers, A.; Gouyer, V.; Huet, G.; Le Bourhis, X.; Delannoy, P.
Glycoconjugate J.
18
883-893
Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines
2003
Marcos, N.T.; Cruz, A.; Silva, F.; Almeida, R.; David, L.; Mandel, U.; Clausen, H.; von Mensdorff-Pouilly, S.; Reis, C.A.
J. Histochem. Cytochem.
51
761-771
Effects of lectin activation on sialyltransferase activities in human lymphocytes
1986
Basu, S.K.; Whisler, R.L.; Yates, A.J.
Biochemistry
25
2577-2581
Biosynthesis in vitro of disialosylneolactotetraosylceramide by a solubilized sialyltransferase from embryonic chicken brain
1985
Higashi, H.; Basu, M.; Basu, S.
J. Biol. Chem.
260
824-828
Purification and characterization of an endogenous inhibitor of the sialyltransferase CMP-N-acetylneuraminate: lactosylceramide alpha 2,6-N-acetylneuraminyltransferase (EC 2.4.99.-)
1988
Albarracin, I.; Lassaga, F.E.; Caputto, R.
Biochem. J.
254
559-565
Activities of five different sialyltransferases in fish and rat brains
1994
Freischutz, B.; Saito, M.; Rahmann, H.; Yu, R.K.
J. Neurochem.
62
1965-1973
Human liver and human placenta both contain CMP-NeuAc:Gal beta 1-->4GlcNAc-R alpha 2-->3- as well as alpha 2-->6-sialyltransferase activity
1992
Nemansky, M.; Schiphorst, W.E.C.M.; Koeleman, C.A.M.; Van den Eijnden, D.H.
FEBS Lett.
312
31-36
Characterization of a sialyl alpha 2-3 transferase and a sialyl alpha 2-6 transferase from human platelets occurring in the sialylation of the N-glycosylproteins
1984
Bauvois, B.; Montreuil, J.; Verbert, A.
Biochim. Biophys. Acta
788
234-240
-
Characterization of sialyltransferase of B16 melanoma cells involved in the formation of melanoma-associated antigen GM3
1993
Tsuchiya, K.; Suzuki, Y.; Mabuchi, K.; Suzuki, T.; Hirabayashi, Y.; Sakiyama, H.
J. Clin. Biochem. Nutr.
14
141-149
Physical and chemical studies on ceruloplasmin. 8. Preparation of N-acetylneuraminic acid-1-14C-labeled ceruloplasmin
1970
Hickman, J.; Ashwell, G.; Morell, A.G.; Van den Hamer, C.J.A.; Scheinberg, I.H.
J. Biol. Chem.
245
759-766
Glycoprotein biosynthesis: studies on thyroglobulin. Thyroid sialyltransferase
1968
Spiro, M.J.; Spiro, R.G.
J. Biol. Chem.
243
6520-6528
Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1-3(4)GlcNAc alpha 2-3 sialyltransferase and a Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase from rat liver
1982
Weinstein, J.; de Souza-e-Silva, U.; Paulson, J.C.
J. Biol. Chem.
257
13845-13853
Purification of a Gal beta 1-4GlcNAc alpha 2-6 sialyltransferase and a Gal beta 1-3(4)GlcNAc alpha 2-3 sialyltransferase to homogeneity from rat liver
1982
Weinstein, J.; de Souza-e-Silva, U.; Paulson, J.C.
J. Biol. Chem.
257
13835-13844
Differential inhibition of rat liver sialyltransferase(s) by various aflatoxins and their metabolites
1975
Bernacki, R.J.; Gurtoo, H.L.
Res. Commun. Chem. Pathol. Pharmacol.
10
681-692
Synthesis of glycoproteins in brain: identification, purification and properties of a synaptosomal sialyl transferase utilizing endogenous and exogenous acceptors
1973
Bosmann, H.B.
J. Neurochem.
20
1037-1049
The sialic acids. XV. Transfer of sialic acid to glycoproteins by a sialyltransferase from colostrum
1973
Bartholomew, B.A.; Jourdian, G.W.; Roseman, S.
J. Biol. Chem.
248
5751-5762
Purification of a sialyltransferase from bovine colostrum by affinity chromatography on CDP-agarose
1977
Paulson, J.C.; Beranek, W.E.; Hill, R.L.
J. Biol. Chem.
252
2356-2362
Enzymatic properties of beta-D-galactoside alpha2 leads to 6 sialytransferase from bovine colostrum
1977
Paulson, J.C.; Rearick, J.I.; Hill, R.L.
J. Biol. Chem.
252
2363-2371
Glycosyltransferases of the human cervical epithelium. II. Characterization of a CMP-N-acetylneuraminate: galactosyl-glycoprotein sialyltransferase
1981
Scudder, P.R.; Chantler, E.N.
Biochim. Biophys. Acta
660
136-141
The role of the carbohydrate chains of Gal beta-1,4-GlcNAc alpha 2,6-sialyltransferase for enzyme activity
1993
Fast, D.G.; Jamieson, J.C.; McCaffrey, G.
Biochim. Biophys. Acta
1202
325-330
Regulation of expression of beta-galactoside alpha 2,6-sialyltransferase in a rat tumor, Zajdela ascitic hepatoma
1993
Jain, N.; Sudhakar, C.; Das, M.R.
FEBS Lett.
317
147-151
Exploring the substrate specificities of alpha-2,6- and alpha-2,3-sialyltransferases using synthetic acceptor analogs
1996
Van Dorst, J.A.L.M.; Tikkanen, J.M.; Krezdorn, C.H.; Streiff, M.B.; Berger, E.G.; Van Kuik, J.A.; Kamerling, J.P.; Vliegenthart, J.F.G.
Eur. J. Biochem.
242
674-681
alpha-(2->3)- and alpha-(2->6)-Sialyltransferase activities present in three variants of Ehrlich tumor cells: identification of the products derived from N-acetyllactosamine and beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->O)-Bn
1994
Shigeta, S.; Winter, H.C.; Goldstein, I.J.
Carbohydr. Res.
264
111-121
The sialyltransferase 'sialylmotif' participates in binding the donor substrate CMP-NeuAc
1995
Datta, A.K.; Paulson, J.C.
J. Biol. Chem.
270
1497-1500
Specific stimulation of alpha 2-6 sialyltransferase activity by a novel cytosolic factor from rat colon
1996
Nagpurkar, A.; Hunt, D.; Mookerjea, S.
Int. J. Biochem. Cell Biol.
28
1337-1348
Purification and characterization of a marine bacterial beta-galactoside alpha 2,6-sialyltransferase from Photobacterium damsela JT0160
1996
Yamamoto, T.; Nakashizuka, M.; Kodama, H.; Kajihara, Y.; Terada, I.
J. Biochem.
120
104-110
-
A novel alpha-2,6-sialyltransferase: transfer of sialic acid to fucosyl and sialyl trisaccharides
1996
Kajihara, Y.; Yamamoto, T.; Nagae, H.; Nakashizuka, M.; Sakakibara, T.; Terada, I.
J. Org. Chem.
61
8632-8635
CMP-NeuAc:Galbeta1->4GlcNAc alpha2->6sialyltransferase catalyzes NeuAc transfer to glycolipids
1997
Nakamura, M.; Tsunoda, A.; Yanagisawa, K.; Furukawa, Y.; Kikuchi, J.; Iwase, S.; Sakai, T.; Larson, G.; Saito, M.
J. Lipid Res.
38
1795-1806
Expression of functional soluble forms of human beta-1,4-galactosyltransferase I, alpha-2,6-sialyltransferase, and alpha-1, 3-fucosyltransferase VI in the methylotrophic yeast Pichia pastoris
2000
Malissard, M.; Zeng, S.; Berger, E.G.
Biochem. Biophys. Res. Commun.
267
169-173
-
Base- and sugar-modified cytidine monophosphate N-acetylneuraminic acid (CMP-Neu5Ac) analogues - synthesis and studies with alpha(2-6)-sialyltransferase from rat liver
2000
Dufner, G.; Schworer, R.; Muller, B.; Schmidt, R.R.
Eur. J. Org. Chem.
8
1467-1482
A rapid, semi-automated method for detection of Galbeta1-4GlcNAc alpha2,6-sialyltransferase (EC 2.4.99.1) activity using the lectin Sambucus nigra agglutinin
2001
Halliday, J.A.W.; Franks, A.H.; Ramsdale, T.E.; Martin, R.; Palant, E.
Glycobiology
11
557-564
Enzymic transfer of sialic acids modified at C-5 employing four different sialyltransferases
1995
Gross, H.J.; Brossmer, R.
Glycoconjugate J.
12
739-746
Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase
2001
Legaigneur, P.; Breton, C.; El Battari, A.; Guillemot, J.C.; Auge, C.; Malissard, M.; Berger, E.G.; Ronin, C.
J. Biol. Chem.
276
21608-21617
High-level expression of human glycosyltransferases in insect cells as biochemically active form
2003
Kim, H.G.; Yang, S.M.; Lee, Y.C.; Do, S.I.; Chung, I.S.; Yang, J.M.
Biochem. Biophys. Res. Commun.
305
488-493
Ganglioside biosynthesis in rat liver. Characterization of three sialyltransferases
1986
Busam, K.; Decker, K.
Eur. J. Biochem.
160
23-30
Substrate specificity of alpha 2->3-sialyltransferases in ganglioside biosynthesis of rat liver Golgi
1991
Iber, H.; van Echten, G.; Sandhoff, K.
Eur. J. Biochem.
195
115-120
The enzymic synthesis of disialoganglioside: rat brain cytidine-5-monophospho-N-acetylneuraminic acid: monosialoganglioside (GM1) sialyltransferase
1973
Yip, M.C.M.
Biochim. Biophys. Acta
306
298-306
Butyrate-induced glycolipid biosynthesis in HeLa cells: properties of the induced sialyltransferase
1976
Fishman, P.H.; Bradley, R.M.; Henneberry, R.C.
Arch. Biochem. Biophys.
172
618-626
Purification and characterization of CMP-NeuAc:GM1 (Galbeta1-4GalNAc) alpha 2-3 sialyltransferase from rat brain
1990
Gu, T.J.; Gu, X.B.; Ariga, T.; Yu, R.K.
FEBS Lett.
275
83-86
Sub-Golgi distribution in rat liver of CMP-NeuAc GM3- and CMP-NeuAc:GT1b alpha 2->8sialyltransferases and comparison with the distribution of the other glycosyltransferase activities involved in ganglioside biosynthesis
1990
Trinchera, M.; Pirovano, B.; Ghidoni, R.
J. Biol. Chem.
265
18242-18247
Regulation of ganglioside metabolism by phosphorylation and dephosphorylation
1998
Bieberich, E.; Freischutz, B.; Liour, S.S.; Yu, R.K.
J. Neurochem.
71
972-979
Regulation of sialyltransferase activities by phosphorylation and dephosphorylation
1995
Gu, X.; Preuss, U.; Gu, T.; Yu, R.K.
J. Neurochem.
64
2295-2302
alpha(1,3)-Fucosyltransferase VII and alpha(2,3)-sialyltransferase IV are up-regulated in activated CD4 T cells and maintained after their differentiation into Th1 and migration into inflammatory sites
1999
Blander, J.M.; Visintin, I.; Janeway, C.A., Jr.; Medzhitov, R.
J. Immunol.
163
3746-3752
Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome
1991
Higgins, E.A.; Siminovitch, K.A.; Zhuang, D.; Brockhausen, I.; Dennis, J.W.
J. Biol. Chem.
266
6280-6290
Biosynthesis of the O-glycosidically linked oligosaccharide chains of fetuin. Indications for an alpha-N-acetylgalactosaminide alpha 2 leads to 6 sialyltransferase with a narrow acceptor specificity in fetal calf liver
1983
Bergh, M.L.E.; Hooghwinkel, G.J.M.; Van den Eijnden, D.H.
J. Biol. Chem.
258
7430-7436
Different reactivity of two brain sialyltransferases towards sulfhydryl reagents. Evidence for a thiol group involved in the nucleotide-sugar binding site of the NeuAc alpha 2-3Gal beta 1-3GalNAc alpha(2-6)sialyltransferase
1989
Baubichon-Cortay, H.; Broquet, P.; George, P.; Louisot, P.
Glycoconjugate J.
6
115-127
Cloning, expression and gene organization of a human Neu5Aca2-3Galb1-3GalNAc a2,6-sialyltransferase: hST6GalNAc IV
2000
Harduin-Lepers, A.; Stokes, D.C.; Steelant, W.F.A.; Samyn-Petit, B.; Krzewinski-Recchi, M.A.; Vallejo-Ruiz, V.; Zanetta, J.P.; Auge, C.; Delannoy, P.
Biochem. J.
352
37-48
Inhibition of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase by nucleotides, nucleotide sugars and nucleotide dialdehydes
1993
Cambron, L.D.; Leskawa, K.C.
Biochem. Biophys. Res. Commun.
193
585-590
Topography of glycosyltransferases involved in the initial glycosylations of gangliosides
1991
Trinchera, M.; Fabbri, M.; Ghidoni, R.
J. Biol. Chem.
266
20907-20912
Purification to apparent homogeneity by immunoaffinity chromatography and partial characterization of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2,3-sialyltransferase (SAT-1), from rat liver Golgi [published erratum appears in J Biol Chem 1991 Oct 15;266(29):19865]
1991
Melkerson-Watson, L.J.; Sweeley, C.C.
J. Biol. Chem.
266
4448-4457
Special considerations in the purification of the GM3 ganglioside-forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): effects of protease inhibitors on rat hepatic SAT-1 activity
1991
Melkerson-Watson, L.J.; Sweeley, C.C.
Biochem. Biophys. Res. Commun.
175
325-332
Special considerations in the purification of the GM3 ganglioside forming enzyme, CMP-sialic acid:lactosylceramide alpha 2-3 sialyltransferase (SAT-1): solubilization of SAT-1 with lauryldimethylamine oxide
1990
Melkerson-Watson, L.J.; Sweeley, C.C.
Biochem. Biophys. Res. Commun.
172
165-171
Purification and characterization of CMP-N-acetylneuraminic acid:lactosylceramide (alpha 2-3) sialyltransferase (GM3-synthase) from rat brain
1993
Preuss, U.; Gu, X.; Gu, T.; Yu, R.K.
J. Biol. Chem.
268
26273-26278
Purification to homogeneity of GD3 synthase and partial purification of GM3 synthase from rat brain
1990
Gu, X.B.; Gu, T.J.; Yu, R.K.
Biochem. Biophys. Res. Commun.
166
387-393
Characterization of a CMP-sialic acid:lactosylceramide sialyltransferase activity in cultured hamster cells
1984
Burczak, J.D.; Fairley, J.L.; Sweeley, C.C.
Biochim. Biophys. Acta
804
442-449
Ganglioside biosynthesis in rat liver: alteration of sialyltransferase activities by nucleotides
1980
Eppler, C.M.; Morré, D.J.; Keenan, T.W.
Biochim. Biophys. Acta
619
332-343
Relationship of membrane phospholipid composition, lactosylceramide molecular species, and the specificity of CMP-N-acetylneuraminate:lactosylceramide alpha 2,3-sialyltransferase to the molecular species composition of GM3 ganglioside
1995
Kadowaki, H.; Grant, M.A.
J. Lipid Res.
36
1274-1282
Cholesterol-containing lactose derived neoglycolipids serve as acceptors for sialyltransferases from rat liver Golgi vesicles
1996
Pohlentz, G.; Mokros, A.; Egge, H.
Glycoconjugate J.
13
147-152
Glycolipid sialyltransferases are enhanced during neural differentiation of mouse embryonic carcinoma cells, P19
1997
Osanai, T.; Watanabe, Y.; Sanai, Y.
Biochem. Biophys. Res. Commun.
241
327-333
The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid
1988
Shaw, L.; Schauer, R.
Biol. Chem. Hoppe-Seyler
369
477-486
Detection of CMP-N-acetylneuraminic acid hydroxylase activity in fractionated mouse liver
1989
Shaw, L.; Schauer, R.
Biochem. J.
263
355-363
Participation of cytochrome b5 in CMP-N-acetylneuraminic acid hydroxylation in mouse liver cytosol
1990
Kozutsumi, Y.; Kawano, T.; Yamakawa, T.; Suzuki, A.
J. Biochem.
108
704-706
Biosynthesis of N-glycolyneuraminic acid. The primary site of hydroxylation of N-acetylneuraminic acid is the cytosolic sugar nucleotide pool
1989
Muchmore, E.A.; Milewski, M.; Varki, A.; Diaz, S.
J. Biol. Chem.
264
20216-20223
CMP-N-acetylneuraminic acid hydroxylase from mouse liver and pig submandibular glands. Interaction with membrane-bound and soluble cytochrome b5-dependent electron transport chains
1994
Shaw, L.; Schneckenburger, P.; Schlenzka, W.; Carlsen, J.; Christiansen, K.; Juergensen, D.; Schauer, R.
Eur. J. Biochem.
219
1001-1011
Cloning and expression of a membrane-bound CMP-N-acetylneuraminic acid hydroxylase from the starfish Asterias rubens
2001
Martensen, I.; Schauer, R.; Shaw, L.
Eur. J. Biochem.
268
5157-5166
Biosynthesis of N-glycolylneuraminic acid-containing glycoconjugates. Purification and characterization of the key enzyme of the cytidine monophospho-N-acetylneuraminic acid hydroxylation system
1994
Kawano, T.; Kozutsumi, Y.; Kawasaki, T.; Suzuki, A.
J. Biol. Chem.
269
9024-9029
Catalytic properties of the CMP-N-acetylneuraminic acid hydroxylase from the starfish Asterias rubens: comparison with the mammalian enzyme
1993
Schlenzka, W.; Shaw, L.; Schauer, R.
Biochim. Biophys. Acta
1161
131-138
Reaction mechanism underlying CMP-N-acetylneuraminic acid hydroxylation in mouse liver: formation of a ternary complex of cytochrome b5, CMP-N-acetylneuraminic acid, and a hydroxylation enzyme
1994
Takematsu, H.; Kawano, T.; Koyama, S.; Kozutsumi, Y.; Suzuki, A.; Kawasaki, T.
J. Biochem.
115
381-386
Purification, characterization and reconstitution of CMP-N-acetylneuraminate hydroxylase from mouse liver
1994
Schneckenburger, P.; Shaw, L.; Schauer, R.
Glycoconjugate J.
11
194-203
A naturally occurring 46-amino acid deletion of cytidine monophospho-N-acetylneuraminic acid hydroxylase leads to a change in the intracellular distribution of the protein
1996
Koyama, S.; Yamaji, T.; Takematsu, H.; Kawano, T.; Kozutsumi, Y.; Suzuki, A.; Kawasaki, T.
Glycoconjugate J.
13
353-358
The role of CMP-N-acetylneuraminic acid hydroxylase in determining the level of N-glycolylneuraminic acid in porcine tissues
1998
Malykh, Y.N.; Shaw, L.; Schauer, R.
Glycoconjugate J.
15
885-893
Cytidine monophosphate-N-acetylneuraminate hydroxylase in the starfish Asterias rubens and other echinoderms
1998
Gollub, M.; Schauer, R.; Shaw, L.
Comp. Biochem. Physiol. B
120
605-615
Isolation and characterization of cytidine-5'-monophosphate-N-acetylneuraminate hydroxylase from the starfish Asterias rubens
2003
Gollub, M.; Shaw, L.
Comp. Biochem. Physiol. B
134
89-101
Purification and characterization of CMP-N-acetylneuraminic acid hydroxylase from pig submandibular glands
1994
Schlenzka, W.; Shaw, L.; Schneckenburger, P.; Schauer, R.
Glycobiology
4
675-683
Mouse liver cytidine-5-monophosphate-N-acetylneuraminic acid hydroxylase. Catalytic function and regulation
1992
Shaw, L.; Schneckenburger, P.; Carlsen, J.; Christiansen, K.; Schauer, R.
Eur. J. Biochem.
206
269-277
Ganglioside biosynthesis in rat liver: characterization of cytidine-5-monophospho-n-acetylneuraminic acid:hematoside (GM3) sialyltransferase
1980
Eppler, C.M.; Morré, D.J.; Keenan, T.W.
Biochim. Biophys. Acta
619
318-331
In vitro biosynthesis of an isomer of brain trisialoganglioside, GT1a
1980
Yohe, H.C.; Yu, R.K.
J. Biol. Chem.
255
608-613
Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments
1999
Effertz, K.; Hinderlich, S.; Reutter, W.
J. Biol. Chem.
274
28771-28778
O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma
2004
Shen, Y.; Kohla, G.; Lrhorfi, A.L.; Sipos, B.; Kalthoff, H.; Gerwig, G.J.; Kamerling, J.P.; Schauer, R.; Tiralongo, J.
Eur. J. Biochem.
271
281-290
Glycosyltransferase activity can be modulated by small conformational changes of acceptor substrates
2003
Galan, M.C.; Venot, A.P.; Boons, G.J.
Biochemistry
42
8522-8529
Development of antibody to human GM3 synthase and immunodetection of the enzyme in human tissues
2004
Golovanova, N.K.; Samovilova, N.N.; Gracheva, E.V.; Peklo, M.M.; Vlasik, T.N.; Sobolev, A.Y.; Jurchenko, Y.V.; Prokazova, N.V.
Biochemistry
69
275-280
Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates
2004
Galan, M.C.; Dodson, C.S.; Venot, A.P.; Boons, G.J.
Bioorg. Med. Chem. Lett.
14
2205-2208
Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen
2004
Marcos, N.T.; Pinho, S.; Grandela, C.; Cruz, A.; Samyn-Petit, B.; Harduin-Lepers, A.; Almeida, R.; Silva, F.; Morais, V.; Costa, J.; Kihlberg, J.; Clausen, H.; Reis, C.A.
Cancer Res.
64
7050-7057
The two rat alpha 2,6-sialyltransferase (ST6Gal I) isoforms: evaluation of catalytic activity and intra-Golgi localization
2003
Chen, T.L.; Chen, C.; Bergeron, N.Q.; Close, B.E.; Bohrer, T.J.; Vertel, B.M.; Colley, K.J.
Glycobiology
13
109-117
Comparison of the enzymatic properties of mouse beta-galactoside alpha2,6-sialyltransferases, ST6Gal I and II
2003
Takashima, S.; Tsuji, S.; Tsujimoto, M.
J. Biochem.
134
287-296
Synthesis of disialyl Lewis a (Le(a)) structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of alpha-series gangliosides
2003
Tsuchida, A.; Okajima, T.; Furukawa, K.; Ando, T.; Ishida, H.; Yoshida, A.; Nakamura, Y.; Kannagi, R.; Kiso, M.
J. Biol. Chem.
278
22787-22794
Functional characterization of Drosophila sialyltransferase
2004
Koles, K.; Irvine, K.D.; Panin, V.M.
J. Biol. Chem.
279
4346-4357
-
Chemoenzymatic synthesis of sialylated oligosaccharides for their evaluation in a polysialyltransferase assay
2003
Sengupta, P.; Misra, A.K.; Suzuki, M.; Fukuda, M.; Hindsgaul, O.
Tetrahedron Lett.
44
6037-6042
Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers
2007
Senda, M.; Ito, A.; Tsuchida, A.; Hagiwara, T.; Kaneda, T.; Nakamura, Y.; Kasama, K.; Kiso, M.; Yoshikawa, K.; Katagiri, Y.; Ono, Y.; Ogiso, M.; Urano, T.; Furukawa, K.; Oshima, S.; Furukawa, K.
Biochem. J.
402
459-470
Human GM3 synthase: a new mRNA variant encodes an NH2-terminal extended form of the protein
2006
Berselli, P.; Zava, S.; Sottocornola, E.; Milani, S.; Berra, B.; Colombo, I.
Biochim. Biophys. Acta
1759
348-358
Regulation of sialic acid O-acetylation in human colon mucosa
2004
Shen, Y.; Tiralongo, J.; Kohla, G.; Schauer, R.
Biol. Chem.
385
145-152
Properties and partial purification of sialate-O-acetyltransferase from bovine submandibular glands
2007
Lrhorfi, L.A.; Srinivasan, G.V.; Schauer, R.
Biol. Chem.
388
297-306
The biosynthesis of 8-O-methylated sialic acids in the starfish Asterias rubens. Isolation and characterisation of S-adenosyl-L-methionine: sialate-8-O-methyltransferase
1998
Kelm, A.; Shaw, L.; Schauer, R.; Reuter, G.
Eur. J. Biochem.
251
874-884
Ganglioside GM3 is involved in neuronal cell death
2006
Sohn, H.; Kim, Y.; Kim, H.; Kim, C.; Cho, E.; Kang, H.; Kim, N.; Kim, C.; Ryu, S.E.; Lee, J.; Ko, J.H.
FASEB J.
20
1248-1250
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity
2006
Julien, S.; Adriaenssens, E.; Ottenberg, K.; Furlan, A.; Courtand, G.; Vercoutter-Edouart, A.S.; Hanisch, F.G.; Delannoy, P.; Le Bourhis, X.
Glycobiology
16
54-64
Molecular cloning and expression of human ST6GalNAc III: restricted tissue distribution and substrate specificity
2005
Tsuchida, A.; Ogiso, M.; Nakamura, Y.; Kiso, M.; Furukawa, K.; Furukawa, K.
J. Biochem.
138
237-243
Roles for UDP-GlcNAc 2-epimerase/ManNAc 6-kinase outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation, and apoptosis, and ERK1/2 phosphorylation
2006
Wang, Z.; Sun, Z.; Li, A.V.; Yarema, K.J.
J. Biol. Chem.
281
27016-27028
Evidence for dynamic interplay of different oligomeric states of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase by biophysical methods
2007
Ghaderi, D.; Strauss, H.M.; Reinke, S.; Cirak, S.; Reutter, W.; Lucka, L.; Hinderlich, S.
J. Mol. Biol.
369
746-758
Identification and analysis of novel functional sites in human GD3-synthase
2008
Gu, Y.; Yu, R.K.
Biochem. Biophys. Res. Commun.
370
67-71
N-Terminal 112 amino acid residues are not required for the sialyltransferase activity of Photobacterium damsela alpha2,6-sialyltransferase
2008
Sun, M.; Li, Y.; Chokhawala, H.A.; Henning, R.; Chen, X.
Biotechnol. Lett.
30
671-676
Cytidine monophospho-N-acetylneuraminic acid hydroxylase (CMAH) mutations associated with the domestic cat AB blood group
2007
Bighignoli, B.; Niini, T.; Grahn, R.A.; Pedersen, N.C.; Millon, L.V.; Polli, M.; Longeri, M.; Lyons, L.A.
BMC Genet.
8
27
Spin-labeled analogs of CMP-NeuAc as NMR probes of the alpha -2,6-sialyltransferase ST6Gal I
2007
Liu, S.; Venot, A.; Meng, L.; Tian, F.; Moremen, K.W.; Boons, G.; Prestegard, J.H.
Chem. Biol.
14
409-418
A beta-galactoside alpha2,6-sialyltransferase produced by a marine bacterium, Photobacterium leiognathi JT-SHIZ-145, is active at pH 8
2007
Yamamoto, T.; Hamada, Y.; Ichikawa, M.; Kajiwara, H.; Mine, T.; Tsukamoto, H.; Takakura, Y.
Glycobiology
17
1167-1174
Crystal structure of Vibrionaceae Photobacterium sp. JT-ISH-224 alpha2,6-sialyltransferase in a ternary complex with donor product CMP and acceptor substrate lactose: catalytic mechanism and substrate recognition
2008
Kakuta, Y.; Okino, N.; Kajiwara, H.; Ichikawa, M.; Takakura, Y.; Ito, M.; Yamamoto, T.
Glycobiology
18
66-73
High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status
2008
Mandal, C.; Srinivasan, G.V.; Chowdhury, S.; Chandra, S.; Mandal, C.; Schauer, R.; Mandal, C.
Glycoconj. J.
26
57-73
Photobacterium sp. JT-ISH-224 produces two sialyltransferases, alpha-/beta-galactoside alpha2,3-sialyltransferase and beta-galactoside alpha2,6-sialyltransferase
2008
Tsukamoto, H.; Takakura, Y.; Mine, T.; Yamamoto, T.
J. Biochem.
143
187-197
Biochemical characterization of the polysialic acid-specific O-acetyltransferase NeuO of Escherichia coli K1
2007
Bergfeld, A.K.; Claus, H.; Vogel, U.; Muehlenhoff, M.
J. Biol. Chem.
282
22217-22227
Biochemical characterization of a Neisseria meningitidis polysialyltransferase reveals novel functional motifs in bacterial sialyltransferases
2007
Freiberger, F.; Claus, H.; Günzel, A.; Oltmann-Norden, I.; Vionnet, J.; Mühlenhoff, M.; Vogel, U.; Vann, W.F.; Gerardy-Schahn, R.; Stummeyer, K.
Mol. Microbiol.
65
1258-1275
Human CMP-N-acetylneuraminic acid hydroxylase (CMAH) is a novel stem cell marker linked to stem cell-specific mechanisms
2010
Nystedt, J.; Anderson, H.; Hirvonen, T.; Impola, U.; Jaatinen, T.; Heiskanen, A.; Blomquist, M.; Satomaa, T.; Natunen, J.; Saarinen, J.; Lehenkari, P.; Valmu, L.; Laine, J.
Stem Cells
28
258-267
Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis
2009
Reinke, S.O.; Lehmer, G.; Hinderlich, S.; Reutter, W.
Biol. Chem.
390
591-599
Synthesis of sialoglycopolypeptide for potentially blocking influenza virus infection using a rat alpha2,6-sialyltransferase expressed in BmNPV bacmid-injected silkworm larvae
2009
Ogata, M.; Nakajima, M.; Kato, T.; Obara, T.; Yagi, H.; Kato, K.; Usui, T.; Park, E.Y.
BMC Biotechnol.
9
54
The second bovine beta-galactoside-alpha2,6-sialyltransferase (ST6Gal II): genomic organization and stimulation of its in vitro expression by IL-6 in bovine mammary epithelial cells
2009
Laporte, B.; Gonzalez-Hilarion, S.; Maftah, A.; Petit, J.M.
Glycobiology
19
1082-1093
An alpha2,6-sialyltransferase cloned from Photobacterium leiognathi strain JT-SHIZ-119 shows both sialyltransferase and neuraminidase activity
2010
Mine, T.; Katayama, S.; Kajiwara, H.; Tsunashima, M.; Tsukamoto, H.; Takakura, Y.; Yamamoto, T.
Glycobiology
20
158-165
Molecular modeling of the bifunctional enzyme UDP-GlcNAc 2-epimerase/ManNAc kinase and predictions of structural effects of mutations associated with HIBM and sialuria
2010
Kurochkina, N.; Yardeni, T.; Huizing, M.
Glycobiology
20
322-337
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells
2010
Prinetti, A.; Aureli, M.; Illuzzi, G.; Prioni, S.; Nocco, V.; Scandroglio, F.; Gagliano, N.; Tredici, G.; Rodriguez-Menendez, V.; Chigorno, V.; Sonnino, S.
Glycobiology
20
62-77
Enhancing of GM3 synthase expression during differentiation of human blood monocytes into macrophages as in vitro model of GM3 accumulation in atherosclerotic lesion
2009
Gracheva, E.V.; Samovilova, N.N.; Golovanova, N.K.; Kashirina, S.V.; Shevelev, A.; Rybalkin, I.; Gurskaya, T.; Vlasik, T.N.; Andreeva, E.R.; Prokazova, N.V.
Mol. Cell. Biochem.
330
121-129
Enhancement of sialylation on humanized IgG-like bispecific antibody by overexpression of alpha2,6-sialyltransferase derived from Chinese hamster ovary cells
2012
Onitsuka, M.; Kim, W.D.; Ozaki, H.; Kawaguchi, A.; Honda, K.; Kajiura, H.; Fujiyama, K.; Asano, R.; Kumagai, I.; Ohtake, H.; Omasa, T.
Appl. Microbiol. Biotechnol.
94
69-80
Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase
2011
Yardeni, T.; Choekyi, T.; Jacobs, K.; Ciccone, C.; Patzel, K.; Anikster, Y.; Gahl, W.A.; Kurochkina, N.; Huizing, M.
Biochemistry
50
8914-8925
Activation of ganglioside GM3 biosynthesis in human blood mononuclear cells in atherosclerosis
2013
Gracheva, E.; Samovilova, N.; Golovanova, N.; Piksina, G.; Shishkina, V.; Prokazova, N.
Biomed. Khim.
59
459-468
CST-IIs recognition domain for acceptor substrates in alpha-(2->8)-sialylations
2011
Li, W.; Zhang, P.; Zuccolo, A.J.; Zheng, R.B.; Ling, C.C.
Carbohydr. Res.
346
1692-1704
Characterization of alpha2,3- and alpha2,6-sialyltransferases from Helicobacter acinonychis
2012
Schur, M.J.; Lameignere, E.; Strynadka, N.C.; Wakarchuk, W.W.
Glycobiology
22
997-1006
Effects of amino acid substitutions in the sialylmotifs on molecular expression and enzymatic activities of alpha2,8-sialyltransferases ST8Sia-I and ST8Sia-VI
2013
Takashima, S.; Matsumoto, T.; Tsujimoto, M.; Tsuji, S.
Glycobiology
23
603-612
Involvement of ST6Gal I in the biosynthesis of a unique human colon cancer biomarker candidate, alpha2,6-sialylated blood group type 2H (ST2H) antigen
2010
Korekane, H.; Matsumoto, A.; Ota, F.; Hasegawa, T.; Misonou, Y.; Shida, K.; Miyamoto, Y.; Taniguchi, N.
J. Biochem.
148
359-370
Disulphide linkage in mouse ST6Gal-I: determination of linkage positions and mutant analysis
2012
Hirano, Y.; Suzuki, T.; Matsumoto, T.; Ishihara, Y.; Takaki, Y.; Kono, M.; Dohmae, N.; Tsuji, S.
J. Biochem.
151
197-203
Role for hepatic and circulatory ST6Gal-1 sialyltransferase in regulating myelopoiesis
2010
Jones, M.B.; Nasirikenari, M.; Feng, L.; Migliore, M.T.; Choi, K.S.; Kazim, L.; Lau, J.T.
J. Biol. Chem.
285
25009-25017
ST6Gal-I regulates macrophage apoptosis via alpha2-6 sialylation of the TNFR1 death receptor
2011
Liu, Z.; Swindall, A.F.; Kesterson, R.A.; Schoeb, T.R.; Bullard, D.C.; Bellis, S.L.
J. Biol. Chem.
286
39654-39662
Sequences prior to conserved catalytic motifs of polysialyltransferase ST8Sia IV are required for substrate recognition
2012
Zapater, J.L.; Colley, K.J.
J. Biol. Chem.
287
6441-6453
Stable coexpression of two human sialylation enzymes in plant suspension-cultured tobacco cells
2011
Kajiura, H.; Misaki, R.; Fujiyama, K.; Seki, T.
J. Biosci. Bioeng.
111
471-477
Decreasing the sialidase activity of multifunctional Pasteurella multocida alpha2-3-sialyltransferase 1 (PmST1) by site-directed mutagenesis
2011
Sugiarto, G.; Lau, K.; Li, Y.; Khedri, Z.; Yu, H.; Le, D.T.; Chen, X.
Mol. Biosyst.
7
3021-3027
Expression of alpha2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas
2010
Tanaka, K.; Mikami, M.; Aoki, D.; Kiguchi, K.; Ishiwata, I.; Iwamori, M.
Oncol. Lett.
1
1061-1066
Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease
2010
Paccalet, T.; Coulombe, Z.; Tremblay, J.P.
PLoS ONE
5
e10055
Metabolism of vertebrate amino sugars with N-glycolyl groups: Elucidating the intracellular fate of the non-human sialic acid N-glycolylneuraminic acid
2012
Bergfeld, A.; Pearce, O.; Diaz, S.; Pham, T.; Varki, A.
J. Biol. Chem.
287
28865-28881
Role of UDP-N-acetylglucosamine2-epimerase/N-acetylmannosamine kinase (GNE) in beta1-integrin-mediated cell adhesion
2014
Grover, S.; Arya, R.
Mol. Neurobiol.
50
257-273
UVB-irradiated keratinocytes induce melanoma-associated ganglioside GD3 synthase gene in melanocytes via secretion of tumor necrosis factor alpha and interleukin 6
2014
Miyata, M.; Ichihara, M.; Tajima, O.; Sobue, S.; Kambe, M.; Sugiura, K.; Furukawa, K.; Furukawa, K.
Biochem. Biophys. Res. Commun.
445
504-510
Alterations of membrane lipids and in gene expression of ganglioside metabolism in different brain structures in a mouse model of mucopolysaccharidosis type I (MPS I)
2013
Kreutz, F.; dos Santos Petry, F.; Camassola, M.; Schein, V.; Guma, F.C.; Nardi, N.B.; Trindade, V.M.
Gene
527
109-114
Expression machinery of GM4: the excess amounts of GM3/GM4S synthase (ST3GAL5) are necessary for GM4 synthesis in mammalian cells
2014
Uemura, S.; Go, S.; Shishido, F.; Inokuchi, J.
Glycoconj. J.
31
101-108
9-O-Acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate
2015
Baumann, A.M.; Bakkers, M.J.; Buettner, F.F.; Hartmann, M.; Grove, M.; Langereis, M.A.; de Groot, R.J.; Muehlenhoff, M.
Nature Commun.
6
7673
GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer
2015
Sarkar, T.R.; Battula, V.L.; Werden, S.J.; Vijay, G.V.; Ramirez-Pena, E.Q.; Taube, J.H.; Chang, J.T.; Miura, N.; Porter, W.; Sphyris, N.; Andreeff, M.; Mani, S.A.
Oncogene
34
2958-2967
The structure of human alpha-2,6-sialyltransferase reveals the binding mode of complex glycans
2013
Kuhn, B.; Benz, J.; Greif, M.; Engel, A.M.; Sobek, H.; Rudolph, M.G.
Acta Crystallogr. Sect. D
69
1826-1838
Sialyltransferase inhibition and recent advances
2016
Wang, L.; Liu, Y.; Wu, L.; Sun, X.L.
Biochim. Biophys. Acta
1864
143-153
A glyco-gold nanoparticle based assay for alpha-2,8-polysialyltransferase from Neisseria meningitidis
2013
Yu, C.C.; Huang, L.D.; Kwan, D.H.; Wakarchuk, W.W.; Withers, S.G.; Lin, C.C.
Chem. Commun. (Camb.)
49
10166-10168
Protein engineering of alpha2,3/2,6-sialyltransferase to improve the yield and productivity of in vitro sialyllactose synthesis
2014
Choi, Y.H.; Kim, J.H.; Park, J.H.; Lee, N.; Kim, D.H.; Jang, K.S.; Park, I.H.; Kim, B.G.
Glycobiology
24
159-169
Sialylation potentials of the silkworm, Bombyx mori; B. mori possesses an active alpha2,6-sialyltransferase
2015
Kajiura, H.; Hamaguchi, Y.; Mizushima, H.; Misaki, R.; Fujiyama, K.
Glycobiology
25
1441-1453
Two N-terminally truncated variants of human beta-galactoside alpha2,6 sialyltransferase I with distinct properties for invitro protein glycosylation
2016
Luley-Goedl, C.; Schmoelzer, K.; Thomann, M.; Malik, S.; Greif, M.; Ribitsch, D.; Jung, C.; Sobek, H.; Engel, A.; Mueller, R.; Schwab, H.; Nidetzky, B.
Glycobiology
26
1097-1106
alpha-2,8-Sialyltransferase is involved in the development of multidrug resistance via PI3K/Akt pathway in human chronic myeloid leukemia
2015
Zhang, X.; Dong, W.; Zhou, H.; Li, H.; Wang, N.; Miao, X.; Jia, L.
IUBMB Life
67
77-87
Synthesis of biologically active N- and O-linked glycans with multisialylated poly-N-acetyllactosamine extensions using P. damsela alpha2-6 sialyltransferase
2013
Nycholat, C.M.; Peng, W.; McBride, R.; Antonopoulos, A.; de Vries, R.P.; Polonskaya, Z.; Finn, M.G.; Dell, A.; Haslam, S.M.; Paulson, J.C.
J. Am. Chem. Soc.
135
18280-18283
Enzymatic basis for N-glycan sialylation: structure of rat alpha2,6-sialyltransferase (ST6GAL1) reveals conserved and unique features for glycan sialylation
2013
Meng, L.; Forouhar, F.; Thieker, D.; Gao, Z.; Ramiah, A.; Moniz, H.; Xiang, Y.; Seetharaman, J.; Milaninia, S.; Su, M.; Bridger, R.; Veillon, L.; Azadi, P.; Kornhaber, G.; Wells, L.; Montelione, G.T.; Woods, R.J.; Tong, L.; Moremen, K.W.
J. Biol. Chem.
288
34680-34698
Analyses of chicken sialyltransferases related to O-glycosylation
2016
Kidani, S.; Kaneoka, H.; Okuzaki, Y.; Asai, S.; Kojima, Y.; Nishijima, K.I.; Iijima, S.
J. Biosci. Bioeng.
122
379-384
High-quality production of human alpha-2,6-sialyltransferase in Pichia pastoris requires control over N-terminal truncations by host-inherent protease activities
2014
Ribitsch, D.; Zitzenbacher, S.; Augustin, P.; Schmoelzer, K.; Czabany, T.; Luley-Goedl, C.; Thomann, M.; Jung, C.; Sobek, H.; Mueller, R.; Nidetzky, B.; Schwab, H.
Microb. Cell Fact.
13
138
Significance of beta-galactoside alpha2,6 sialyltranferase 1 in cancers
2015
Lu, J.; Gu, J.
Molecules
20
7509-7527
N-acetylgalactosaminide alpha2,6-sialyltransferase II is a candidate enzyme for sialylation of galactose-deficient IgA1, the key autoantigen in IgA nephropathy
2015
Stuchlova Horynova, M.; Vrablikova, A.; Stewart, T.J.; Takahashi, K.; Czernekova, L.; Yamada, K.; Suzuki, H.; Julian, B.A.; Renfrow, M.B.; Novak, J.; Raska, M.
Nephrol. Dial. Transplant.
30
234-238
Enhanced bacterial alpha(2,6)-sialyltransferase reaction through an inhibition of its inherent sialidase activity by dephosphorylation of cytidine-5'-monophosphate
2015
Kang, J.Y.; Lim, S.J.; Kwon, O.; Lee, S.G.; Kim, H.H.; Oh, D.B.
PLoS ONE
10
e0133739
A new assay for determining ganglioside sialyltransferase activities lactosylceramide-2,3-sialyltransferase (SAT I) and monosialylganglioside-2,3-sialyltransferase (SAT IV)
2014
Sun, C.Q.; Hubl, U.; Hoefakker, P.; Vasudevamurthy, M.K.; Johnson, K.D.
PLoS ONE
9
e94206
A sialyltransferase mutant with decreased donor hydrolysis and reduced sialidase activities for directly sialylating Lewisx
2012
Sugiarto, G.; Lau, K.; Qu, J.; Li, Y.; Lim, S.; Mu, S.; Ames, J.B.; Fisher, A.J.; Chen, X.
ACS Chem. Biol.
7
1232-1240
Molecular cloning and expression of human Galbeta1,3GalNAc alpha2,3-sialyltransferase (hST3Gal II)
1996
Kim, Y.J.; Kim, K.S.; Kim, S.H.; Kim, C.H.; Ko, J.H.; Choe, I.S.; Tsuji, S.; Lee, Y.C.
Biochem. Biophys. Res. Commun.
228
324-327
A systematic analysis of acceptor specificity and reaction kinetics of five human alpha(2,3)sialyltransferases Product inhibition studies illustrate reaction mechanism for ST3Gal-I
2016
Gupta, R.; Matta, K.L.; Neelamegham, S.
Biochem. Biophys. Res. Commun.
469
606-612
Effects of lectin activation on sialyltransferase activities in human lymphocytes
1986
Basu, S.K.; Whisler, R.L.; Yates, A.J.
Biochemistry
25
2577-2581
Kinetic properties and acceptor substrate preferences of two kinds of Gal beta 1,3GalNAc alpha 2,3-sialyltransferase from mouse brain
1994
Kojima, N.; Lee, Y.C.; Hamamoto, T.; Kurosawa, N.; Tsuji, S.
Biochemistry
33
5772-5776
Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. Identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase
2005
Chandrasekaran, E.V.; Xue, J.; Xia, J.; Chawda, R.; Piskorz, C.; Locke, R.D.; Neelamegham, S.; Matta, K.L.
Biochemistry
44
15619-15635
Delineation of the minimal catalytic domain of human Galbeta1-3GalNAc alpha2,3-sialyltransferase (hST3Gal I)
2001
Vallejo-Ruiz, V.; Haque, R.; Mir, A.M.; Schwientek, T.; Mandel, U.; Cacan, R.; Delannoy, P.; Harduin-Lepers, A.
Biochim. Biophys. Acta
1549
161-173
Characterization of a sialyl alpha 2-3 transferase and a sialyl alpha 2-6 transferase from human platelets occurring in the sialylation of the N-glycosylproteins
1984
Bauvois, B.; Montreuil, J.; Verbert, A.
Biochim. Biophys. Acta
788
234-240
Production and purification of secretory simian cytidine monophosphate-N-acetylneuraminic acid hydroxylase using baculovirus-protein expression system
2015
Takahashi, T.; Kawagishi, S.; Funahashi, H.; Hayashi, N.; Suzuki, T.
Biol. Pharm. Bull.
38
1220-1226
Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a gamma-polyglutamic acid backbone and their effect on inhibition of infection by influenza viruses
2007
Ogata, M.; Murata, T.; Murakami, K.; Suzuki, T.; Hidari, K.I.; Suzuki, Y.; Usui, T.
Bioorg. Med. Chem.
15
1383-1393
Efficient enzymatic synthesis of 4-methylumbelliferyl N-acetyllactosaminide and 4-methylumbelliferyl sialyl N-acetyllactosaminides employing beta-D-galactosidase and sialyltransferases
2005
Zeng, X.; Sun, Y.; Uzawa, H.
Biotechnol. Lett.
27
1461-1465
Coordinated roles of ST3Gal-VI and ST3Gal-IV sialyltransferases in the synthesis of selectin ligands
2012
Yang, W.H.; Nussbaum, C.; Grewal, P.K.; Marth, J.D.; Sperandio, M.
Blood
120
1015-1026
Use of the core-2-N-acetylglucosaminyltransferase in the chemical-enzymic synthesis of a sialyl-LeX-containing hexasaccharide found on O-linked glycoproteins
1993
Oehrlein, R.; Hindsgaul, O.; Palcic, M.M.
Carbohydr. Res.
244
149-159
alpha-(2->3)- and alpha-(2->6)-Sialyltransferase activities present in three variants of Ehrlich tumor cells identification of the products derived from N-acetyllactosamine and beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->O)-Bn
1994
Shigeta, S.; Winter, H.C.; Goldstein, I.J.
Carbohydr. Res.
264
111-121
Substrate specificity of GM2 and GD3 synthase of Golgi vesicles derived from rat liver
1987
Klein, D.; Pohlentz, G.; Schwarzmann, G.; Sandhoff, K.
Eur. J. Biochem.
167
417-424
Molecular cloning and expression of Galbeta1,3GalNAcalpha2,3-sialyltransferase from mouse brain
1993
Lee, Y.C.; Kurosawa, N.; Hamamoto, T.; Nakaoka, T.; Tsuji, S.
Eur. J. Biochem.
216
377-385
Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line
1997
Giordanengo, V.; Bannwarth, S.; Laffont, C.; Van Miegem, V.; Harduin-Lepers, A.; Delannoy, P.; Lefebvre, J.C.
Eur. J. Biochem.
247
558-566
Human liver and human placenta both contain CMP-NeuAc Gal beta 1->4GlcNAc-R alpha 2->3- as well as alpha 2->6-sialyltransferase activity
1992
Nemansky, M.; Schiphorst, W.E.C.M.; Koeleman, C.A.M.; Van den Eijnden, D.H.
FEBS Lett.
312
31-36
A novel viral alpha2,3-sialyltransferase (v-ST3Gal I) transfer of sialic acid to fucosylated acceptors
2000
Sujino, K.; Jackson, R.J.; Chan, N.W.C.; Tsuji, S.; Palcic, M.M.
Glycobiology
10
313-320
Characterization of alpha2,3- and alpha2,6-sialyltransferases from Helicobacter acinonychis
2012
Schur, M.J.; Lameignere, E.; Strynadka, N.C.; Wakarchuk, W.W.
Glycobiology
22
997-1006
Mouse beta-galactoside alpha2,3-sialyltransferases comparison of in vitro substrate specificities and tissue specific expression
1997
Kono, M.; Ohyama, Y.; Lee, Y.C.; Hamamoto, T.; Kojima, N.; Tsuji, S.
Glycobiology
7
469-479
Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells
2005
Peracaula, R.; Tabares, G.; Lopez-Ferrer, A.; Brossmer, R.; de Bolos, C.; de Llorens, R.
Glycoconj. J.
22
135-144
The evolution of galactose alpha2,3-sialyltransferase Ciona intestinalis ST3GAL I/II and Takifugu rubripes ST3GAL II sialylate Galbeta1,3GalNAc structures on glycoproteins but not glycolipids
2008
Lehmann, F.; Kelm, S.; Dietz, F.; von Itzstein, M.; Tiralongo, J.
Glycoconj. J.
25
323-334
Enzymic characterization of CMP-NeuAc Gal-beta-1,4GlcNAc-R alpha(2,3)-sialyltransferase from human placenta
1993
Nemansky, M.; Van den Eijnden, D.H.
Glycoconjugate J.
10
99-108
alpha2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues
2013
Perez-Garay, M.; Arteta, B.; Llop, E.; Cobler, L.; Pages, L.; Ortiz, R.; Ferri, M.J.; de Bolos, C.; Figueras, J.; de Llorens, R.; Vidal-Vanaclocha, F.; Peracaula, R.
Int. J. Biochem. Cell Biol.
34
1748-1757
Expression of gangliosides, GD1a, and sialyl paragloboside is regulated by NF-kappaB-dependent transcriptional control of alpha2,3-sialyltransferase I, II, and VI in human castration-resistant prostate cancer cells
2011
Hatano, K.; Miyamoto, Y.; Nonomura, N.; Kaneda, Y.
Int. J. Cancer
129
1838-1847
Identification and characterization of a lipopolysaccharide alpha,2,3-sialyltransferase from the human pathogen Helicobacter bizzozeronii
2012
Kondadi, P.K.; Rossi, M.; Twelkmeyer, B.; Schur, M.J.; Li, J.; Schott, T.; Paulin, L.; Auvinen, P.; Haenninen, M.L.; Schweda, E.K.; Wakarchuk, W.
J. Bacteriol.
194
2540-2550
Molecular cloning, expression and properties of an alpha/beta-galactoside alpha2,3-sialyltransferase from Vibrio sp. JT-FAJ-16
2007
Takakura, Y.; Tsukamoto, H.; Yamamoto, T.
J. Biochem.
142
403-412
Photobacterium sp. JT-ISH-224 produces two sialyltransferases, alpha-/beta-galactoside alpha2,3-sialyltransferase and beta-galactoside alpha2,6-sialyltransferase
2008
Tsukamoto, H.; Takakura, Y.; Mine, T.; Yamamoto, T.
J. Biochem.
143
187-197
Accelerated biosynthesis of neolacto-series glycosphingolipids in differentiated mouse embryonal carcinoma F9 cells detected by using dodecyl N-acetylglucosaminide as a saccharide primer
2011
Ogasawara, N.; Katagiri, Y.U.; Kiyokawa, N.; Kaneko, T.; Sato, B.; Nakajima, H.; Miyagawa, Y.; Kushi, Y.; Ishida, H.; Kiso, M.; Okita, H.; Sato, T.; Fujimoto, J.
J. Biochem.
149
321-330
Purification to homogeneity of a beta-galactoside alpha2 leads to 3 sialyltransferase and partial purification of an alpha-N-acetylgalactosaminide alpha2 leads to 6 sialyltransferase from porcine submaxillary glands
1979
Sadler, J.E.; Rearick, J.I.; Paulson, J.C.; Hill, R.L.
J. Biol. Chem.
254
4434-4443
Enzymatic characterization of beta D-galactoside alpha2 leads to 3 sialyltransferase from porcine submaxillary gland
1979
Rearick, J.I.; Sadler, J.E.; Paulson, J.C.; Hill, R.L.
J. Biol. Chem.
254
4444-4451
Detection of beta-galactosyl(1->4)N-acetylglucosaminide alpha(2->3)-sialyltransferase activity in fetal calf liver and other tissues
1981
Van den Eijnden, D.H.; Schiphorst, W.E.C.M.
J. Biol. Chem.
256
3159-3162
Biosynthesis in vitro of sialyl(alpha 2-3)neolactotetraosylceramide by a sialyltransferase from embryonic chicken brain
1982
Basu, M.; Basu, S.; Stoffyn, A.; Stoffyn, P.
J. Biol. Chem.
257
12765-12769
Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome
1991
Higgins, E.A.; Siminovitch, K.A.; Zhuang, D.; Brockhausen, I.; Dennis, J.W.
J. Biol. Chem.
266
6280-6290
Human alpha2,3-sialyltransferase (ST3Gal II) is a stage-specific embryonic antigen-4 synthase
2003
Saito, S.; Aoki, H.; Ito, A.; Ueno, S.; Wada, T.; Mitsuzuka, K.; Satoh, M.; Arai, Y.; Miyagi, T.
J. Biol. Chem.
278
26474-26479
Purification, cloning, and expression of an alpha/beta-galactoside alpha-2,3-sialyltransferase from a luminous marine bacterium, Photobacterium phosphoreum
2007
Tsukamoto, H.; Takakura, Y.; Yamamoto, T.
J. Biol. Chem.
282
29794-29802
Cyclooxygenase-2 enzyme induces the expression of the alpha-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer
2012
Sproviero, D.; Julien, S.; Burford, B.; Taylor-Papadimitriou, J.; Burchell, J.M.
J. Biol. Chem.
287
44490-44497
Analyses of chicken sialyltransferases related to N-glycosylation
2015
Kojima, Y.; Mizutani, A.; Okuzaki, Y.; Nishijima, K.; Kaneoka, H.; Sasamoto, T.; Miyake, K.; Iijima, S.
J. Biosci. Bioeng.
119
623-628
Analyses of chicken sialyltransferases related to O-glycosylation
2016
Kidani, S.; Kaneoka, H.; Okuzaki, Y.; Asai, S.; Kojima, Y.; Nishijima, K.I.; Iijima, S.
J. Biosci. Bioeng.
122
379-384
-
Substrate specificity and preparative use of recombinant rat ST3Gal III
2004
Schwardt, O.; Gao, G.P.; Visekruna, T.; Rabbani, S.; Gassmann, E.; Ernst, B.
J. Carbohydr. Chem.
23
1-26
Production of alpha1,3-galactosyltransferase and cytidine monophosphate-N-acetylneuraminic acid hydroxylase gene double-deficient pigs by CRISPR/Cas9 and handmade cloning
2017
Gao, H.; Zhao, C.; Xiang, X.; Li, Y.; Zhao, Y.; Li, Z.; Pan, D.; Dai, Y.; Hara, H.; Cooper, D.K.; Cai, Z.; Mou, L.
J. Reprod. Dev.
63
17-26
A novel variant in CMAH is associated with blood type AB in Ragdoll cats
2016
Gandolfi, B.; Grahn, R.A.; Gustafson, N.A.; Proverbio, D.; Spada, E.; Adhikari, B.; Cheng, J.; Andrews, G.; Lyons, L.A.; Helps, C.R.
PLoS ONE
11
e0154973
Molecular characterization of the cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMAH) gene associated with the feline AB blood group system
2016
Omi, T.; Nakazawa, S.; Udagawa, C.; Tada, N.; Ochiai, K.; Chong, Y.H.; Kato, Y.; Mitsui, H.; Gin, A.; Oda, H.; Azakami, D.; Tamura, K.; Sako, T.; Inagaki, T.; Sakamoto, A.; Tsutsui, T.; Bonkobara, M.; Tsuchida, S.; Ikemoto, S.
PLoS ONE
11
e0165000
Both GA2, GM2, and GD2 synthases and GM1b, GD1a, and GT1b synthases are single enzymes in Golgi vesicles from rat liver
1988
Pohlentz, G.; Klein, D.; Schwarzmann, G.; Schmitz, D.; Sandhoff, K.
Proc. Natl. Acad. Sci. USA
85
7044-7048
-
Chemoenzymatic synthesis of sialylated oligosaccharides for their evaluation in a polysialyltransferase assay
2003
Sengupta, P.; Misra, A.K.; Suzuki, M.; Fukuda, M.; Hindsgaul, O.
Tetrahedron Lett.
44
6037-6042
The tetrameric structure of sialic-acid-synthesizing UDP-GlcNAc 2-epimerase from Acinetobacter baumannii a comparative study with human GNE
2018
Ko, T.P.; Lai, S.J.; Hsieh, T.J.; Yang, C.S.; Chen, Y.
J. Biol. Chem.
293
10119-10127
Mechanism and inhibition of human UDP-GlcNAc 2-epimerase, the key enzyme in sialic acid biosynthesis
2016
Chen, S.C.; Huang, C.H.; Lai, S.J.; Yang, C.S.; Hsiao, T.H.; Lin, C.H.; Fu, P.K.; Ko, T.P.; Chen, Y.
Sci. Rep.
6
23274
Assay development and screening for the identification of ganglioside GM3 synthase inhibitors
2020
Yamanaka, K.; Takahashi, Y.; Azuma, Y.; Hantani, Y.
Biochemistry
59
1242-1251
Biosynthesis of a disialylated sequence in N-linked oligosaccharides Identification of an N-acetylglucosaminide (alpha2->6)-sialyltransferase in Golgi apparatus from rat liver
1984
Paulson, J.; Weinstein, J.; de Souza-e-Silva, U.
Eur. J. Biochem.
140
523-530
Purification of a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase and a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase to homogeneity from rat liver
1982
Weinstein, J.; de Souza-e-Silva, U.; Paulson, J.
J. Biol. Chem.
257
13835-13844
Sialylation of glycoprotein oligosaccharides N-linked to asparagine. Enzymatic characterization of a Gal beta 1 to 3(4)GlcNAc alpha 2 to 3 sialyltransferase and a Gal beta 1 to 4GlcNAc alpha 2 to 6 sialyltransferase from rat liver
1982
Weinstein, J.; de Souza-e-Silva, U.; Paulson, J.
J. Biol. Chem.
257
13845-13853
Selective engineering of linkage-specific alpha2,6-N-linked sialoproteins using sydnone-modified sialic acid bioorthogonal reporters
2019
Chinoy, Z.S.; Bodineau, C.; Favre, C.; Moremen, K.W.; Duran, R.V.; Friscourt, F.
Angew. Chem. Int. Ed. Engl.
58
4281-4285
Exploiting the disialyl galactose activity of alpha2,6-sialyltransferase from Photobacterium damselae to generate a highly sialylated recombinant alpha-1-antitrypsin
2020
Pallister, E.G.; Choo, M.S.F.; Tai, J.N.; Leong, D.S.Z.; Tang, W.Q.; Ng, S.K.; Huang, K.; Marchesi, A.; Both, P.; Gray, C.; Rudd, P.M.; Flitsch, S.L.; Nguyen-Khuong, T.
Biochemistry
59
3123-3128
Possible contribution of alpha2,6-sialylation to luteolysis in cows by inhibiting the luteotropic effects of galectin-1
2016
Hashiba, K.; Nio-Kobayashi, J.; Sano, M.; Maeda, M.; Kimura, Y.; Yamamoto, Y.; Kimura, K.; Okuda, K.
Biol. Reprod.
95
17
CRISPR-based targeted epigenetic editing enables gene expression modulation of the silenced beta-galactoside alpha-2,6-sialyltransferase 1 in CHO cells
2018
Marx, N.; Gruenwald-Gruber, C.; Bydlinski, N.; Dhiman, H.; Ngoc Nguyen, L.; Klanert, G.; Borth, N.
Biotechnol. J.
13
e1700217
alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice
2017
Eby, J.M.; Barse, L.; Henning, S.W.; Rabelink, M.J.; Klarquist, J.; Gilbert, E.R.; Hammer, A.M.; Fernandez, M.F.; Yung, N.; Khan, S.; Miller, H.G.; Kessler, E.R.; Garrett-Mayer, E.; Dilling, D.F.; Hoeben, R.C.; Le Poole, I.C.
Cancer Immunol. Immunother.
66
63-75
The beta-galactoside alpha2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation
2019
Zhou, L.; Zhang, S.; Zou, X.; Lu, J.; Yang, X.; Xu, Z.; Shan, A.; Jia, W.; Liu, F.; Yan, X.; Su, H.; Liang, T.; Zheng, M.; Zhang, Y.; Feng, B.
Cancer Manag. Res.
11
6185-6199
Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases
2019
Uslupehlivan, M.; Sener, E.; Izzetoglu, S.
Carbohydr. Res.
486
107823
Alginate oligosaccharide attenuates alpha2,6-sialylation modification to inhibit prostate cancer cell growth via the Hippo/YAP pathway
2019
Han, Y.; Zhang, L.; Yu, X.; Wang, S.; Xu, C.; Yin, H.; Wang, S.
Cell Death Dis.
10
374
An alpha2,3-sialyltransferase from Photobacterium phosphoreum with broad substrate scope Controlling hydrolytic activity by directed evolution
2020
Fessner, W.D.; Mertsch, A.; He, N.; Yi, D.; Kickstein, M.
Chem. Eur. J.
26
11614-11624
Probing the CMP-sialic acid donor specificity of two human beta-D-galactoside sialyltransferases (ST3Gal I and ST6gal I) selectively acting on O- and N-glycosylproteins
2017
Noel, M.; Gilormini, P.A.; Cogez, V.; Yamakawa, N.; Vicogne, D.; Lion, C.; Biot, C.; Guerardel, Y.; Harduin-Lepers, A.
ChemBioChem
18
1251-1259
The intrinsic relationship between structure and function of the sialyltransferase ST8Sia family members
2017
Huang, R.B.; Cheng, D.; Liao, S.M.; Lu, B.; Wang, Q.Y.; Xie, N.Z.; Troy Ii, F.A.; Zhou, G.P.
Curr. Top. Med. Chem.
17
2359-2369
ST3GAL3, ST3GAL4, and ST3GAL6 differ in their regulation of biological functions via the specificities for the alpha2,3-sialylation of target proteins
2020
Qi, F.; Isaji, T.; Duan, C.; Yang, J.; Wang, Y.; Fukuda, T.; Gu, J.
FASEB J.
34
881-897
Analyses of N-linked glycans of PrPSc revealed predominantly 2,6-linked sialic acid residues
2017
Katorcha, E.; Baskakov, I.
FEBS J.
284
3727-3738
Comparison of alpha2,6-sialyltransferases for sialylation of therapeutic proteins
2019
Janesch, B.; Saxena, H.; Sim, L.; Wakarchuk, W.W.
Glycobiology
29
735-747
Upregulation of human ST8Sia VI (alpha2,8-sialyltransferase) gene expression by physcion in SK-N-BE(2)-C human neuroblastoma cells
2016
Yoon, H.K.; An, H.K.; Ko, M.J.; Kim, K.S.; Mun, S.W.; Kim, D.H.; Kim, C.M.; Kim, C.H.; Choi, Y.W.; Lee, Y.C.
Int. J. Mol. Sci.
17
1246
Novel zebrafish mono-alpha2,8-sialyltransferase (ST8Sia VIII) an evolutionary perspective of alpha2,8-sialylation
2019
Chang, L.Y.; Teppa, E.; Noel, M.; Gilormini, P.A.; Decloquement, M.; Lion, C.; Biot, C.; Mir, A.M.; Cogez, V.; Delannoy, P.; Khoo, K.H.; Petit, D.; Guerardel, Y.; Harduin-Lepers, A.
Int. J. Mol. Sci.
20
622
Sequence requirements for neuropilin-2 recognition by ST8SiaIV and polysialylation of its O-glycans
2016
Bhide, G.P.; Fernandes, N.R.; Colley, K.J.
J. Biol. Chem.
291
9444-9457
The inhibitory Role of alpha2,6-sialylation in adipogenesis
2017
Kaburagi, T.; Kizuka, Y.; Kitazume, S.; Taniguchi, N.
J. Biol. Chem.
292
2278-2286
Production of alpha2,6-sialylated and non-fucosylated recombinant alpha-1-antitrypsin in CHO cells
2020
Lalonde, M.E.; Koyuturk, I.; Brochu, D.; Jabbour, J.; Gilbert, M.; Durocher, Y.
J. Biotechnol.
307
87-97
miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1
2018
Han, Y.; Liu, Y.; Fu, X.; Zhang, Q.; Huang, H.; Zhang, C.; Li, W.; Zhang, J.
J. Physiol. Biochem.
74
491-501
Porcine sapelovirus uses alpha2,3-linked sialic acid on GD1a ganglioside as a receptor
2016
Kim, D.S.; Son, K.Y.; Koo, K.M.; Kim, J.Y.; Alfajaro, M.M.; Park, J.G.; Hosmillo, M.; Soliman, M.; Baek, Y.B.; Cho, E.H.; Lee, J.H.; Kang, M.I.; Goodfellow, I.; Cho, K.O.
J. Virol.
90
4067-4077
MiR-193a-3p and miR-224 mediate renal cell carcinoma progression by targeting alpha-2,3-sialyltransferase IV and the phosphatidylinositol 3 kinase/Akt pathway
2018
Pan, Y.; Hu, J.; Ma, J.; Qi, X.; Zhou, H.; Miao, X.; Zheng, W.; Jia, L.
Mol. Carcinog.
57
1067-1077
ST6GAL1 A key player in cancer
2019
Garnham, R.; Scott, E.; Livermore, K.; Munkley, J.
Oncol. Lett.
18
983-989
Elevation of beta-galactoside alpha2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis
2017
Hsieh, C.C.; Shyr, Y.M.; Liao, W.Y.; Chen, T.H.; Wang, S.E.; Lu, P.C.; Lin, P.Y.; Chen, Y.B.; Mao, W.Y.; Han, H.Y.; Hsiao, M.; Yang, W.B.; Li, W.S.; Sher, Y.P.; Shen, C.N.
Oncotarget
8
7691-7709
A Golgi-associated redox switch regulates catalytic activation and cooperative functioning of ST6Gal-I with B4GalT-I
2019
Hassinen, A.; Khoder-Agha, F.; Khosrowabadi, E.; Mennerich, D.; Harrus, D.; Noel, M.; Dimova, E.Y.; Glumoff, T.; Harduin-Lepers, A.; Kietzmann, T.; Kellokumpu, S.
Redox Biol.
24
101182
Transition state-based ST6Gal I inhibitors Mimicking the phosphodiester linkage with a triazole or carbamate through an enthalpy-entropy compensation
2017
Montgomery, A.P.; Skropeta, D.; Yu, H.
Sci. Rep.
7
14428
Structural and functional role of disulphide bonds and substrate binding residues of the human beta-galactoside alpha-2,3-sialyltransferase 1 (hST3Gal1)
2019
Ortiz-Soto, M.E.; Reising, S.; Schlosser, A.; Seibel, J.
Sci. Rep.
9
17993
Functional roles of ST8SIA3-mediated sialylation of striatal dopamine D2 and adenosine A2A receptors
2019
Lin, C.; Lai, H.; Chen, H.; Siew, J.; Hsiao, C.; Chang, H.; Liao, K.; Tsai, S.; Wu, C.; Kitajima, K.; Sato, C.; Khoo, K.; Chern, Y.
Transl. Psychiatry
9
209
Ginsenosides, potent inhibitors of sialyltransferase
2020
Huang, W.; Sun, L.; Wang, B.; Ma, Y.; Yao, D.; Han, W.; Wang, L.
Z. Naturforsch. C
75
41-49
A novel monosialoganglioside synthesized by a rat brain cytidine-5'-monophospho-N-acetylneuraminic acid galactosyl-N-acetylgalactosaminyl-galactosyl-glucosylceramide sialyltransferase
1973
Yip, M.
Biochem. Biophys. Res. Commun.
53
737-744
The alpha2,8-sialyltransferase 6 (St8sia6) localizes in the ER and enhances the anchorage-independent cell growth in cancer
2022
Hatanaka, R.; Araki, E.; Hane, M.; Go, S.; Wu, D.; Kitajima, K.; Sato, C.
Biochem. Biophys. Res. Commun.
608
52-58
Isolation and functional analysis of the promoter of the rat CMP-NeuAc GM3 alpha 2,8 sialyltransferase gene
1998
Zeng, G.; Gao, L.; Yu, R.
Biochim. Biophys. Acta
1397
126-130
Tumor hypoxia regulates ganglioside GM3 synthase, which contributes to oxidative stress resistance in malignant melanoma
2020
Shimizu, T.; Nagane, M.; Suzuki, M.; Yamauchi, A.; Kato, K.; Kawashima, N.; Nemoto, Y.; Maruo, T.; Kawakami, Y.; Yamashita, T.
Biochim. Biophys. Acta Gen. Subj.
1864
129723
Engineering analysis of multienzyme cascade reactions for 3'-sialyllactose synthesis
2021
Schelch, S.; Eibinger, M.; Gross Belduma, S.; Petschacher, B.; Kuballa, J.; Nidetzky, B.
Biotechnol. Bioeng.
118
4290-4304
Expression of alpha2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines high level expression in melanomas and up-regulation in activated T lymphocytes
1995
Yamashiro, S.; Okada, M.; Haraguchi, M.; Furukawa, K.; Lloyd, K.; Shiku, H.; Furukawa, K.
Glycoconj. J.
12
894-900
Analysis of biochemical features of ST8 alpha-N-acetyl-neuraminide alpha2,8-sialyltransferase (St8sia) 5 isoforms
2022
Araki, E.; Hane, M.; Hatanaka, R.; Kimura, R.; Tsuda, K.; Konishi, M.; Komura, N.; Ando, H.; Kitajima, K.; Sato, C.
Glycoconj. J.
39
291-302
Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor alpha-mediated beta-galactoside alpha2,6-sialyltransferase I expression in human hepatocarcinoma cells
2021
Chen, X.; Wang, L.; Yu, X.; Wang, S.; Zhang, J.
Int. J. Biochem. Cell Biol.
137
106027
Cloning, characterization and developmental expression of alpha2,8 sialyltransferase (GD3 synthase, ST8Sia I) gene in chick brain and retina
1997
Daniotti, J.; Fritz, V.; Kunda, P.; Nishi, T.; Maccioni, H.
Int. J. Dev. Neurosci.
15
767-776
Knockdown of alpha2,3-sialyltransferases impairs pancreatic cancer cell migration, invasion and E-selectin-dependent adhesion
2020
Guerrero, P.; Miro, L.; Wong, B.; Massaguer, A.; Martinez-Bosch, N.; de Llorens, R.; Navarro, P.; Konstantopoulos, K.; Llop, E.; Peracaula, R.
Int. J. Mol. Sci.
21
1-24
CMP-NeuNAc poly-alpha-2,8-sialosyl sialyltransferase and the biosynthesis of polysialosyl units in neural cell adhesion molecules
1985
McCoy, R.; Vimr, E.; Troy, F.
J. Biol. Chem.
260
12695-12699
Expression cloning of a human GT3 synthase GD3 and GT3 are synthesized by a single enzyme
1996
Nakayama, J.; Fukuda, M.; Hirabayashi, Y.; Kanamori, A.; Sasaki, K.; Nishi, T.; Fukuda, M.
J. Biol. Chem.
271
3684-3691
The enzymic synthesis of GM1b rat-brain CMP-N-acetylneuraminic acid sialo-GM1 sialyltransferase
1981
Yip, M.; Nguyen, N.
Lipids
16
72-74
CMP-NeuNAc poly-alpha-2,8-sialosyl sialyltransferase in neural cell membranes
1987
McCoy, R.; Troy, F.
Methods Enzymol.
138
627-637
more
Show all BRENDA pathways known for CMP-N-acetylneuraminate
close all tables 
open all tables
top
